Osamu Ogawa

Q: What Schools Are Affiliated With Osamu Ogawa

Osamu Ogawa is affiliated with the following schools: Akita University, Kyoto University

Osamu Ogawa's AcademicInfluence.com Rankings

Osamu Ogawa

Philosophy

#7029

World Rank

#10176

Historical Rank

Logic

#4107

World Rank

#5357

Historical Rank

philosophy Degrees

Osamu Ogawa

Biology

#9529

World Rank

#12744

Historical Rank

Genetics

#977

World Rank

#1073

Historical Rank

Molecular Biology

#1321

World Rank

#1348

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Osamu Ogawa's Degrees

PhD Molecular Biology University of Tokyo
Doctorate Medicine University of Tokyo

Why Is Osamu Ogawa Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Osamu Ogawa's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour (1993) (724)
Gene expression levels and immunolocalization of organic ion transporters in the human kidney. (2002) (504)
Risk Factors for Prostate Cancer (2004) (404)
Salt-sensitive hypertension in circadian clock–deficient Cry-null mice involves dysregulated adrenal Hsd3b6 (2010) (380)
Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. (2007) (378)
Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. (2006) (347)
Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. (1995) (324)
Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population (2010) (293)
Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. (2001) (199)
Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. (2000) (195)
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. (2020) (191)
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases (2020) (191)
Collagenous matrices as release carriers of exogenous growth factors. (2004) (190)
Mosaic and polymorphic imprinting of the WT1 gene in humans (1994) (174)
Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine (2004) (171)
Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient. (2005) (165)
Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect. (2000) (165)
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus (2014) (156)
Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant. (2004) (150)
Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. (1997) (150)
Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. (1995) (146)
Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. (2002) (143)
Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. (1991) (142)
Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. (1993) (122)
Transperitoneal laparoscopic adrenalectomy: experience in 100 patients. (1997) (121)
XISTunmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer (2004) (118)
Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990-2000 in Japan. (2004) (117)
Constitutional relaxation of insulin–like growth factor II gene imprinting associated with Wilms' tumour and gigantism (1993) (116)
Type I collagen can function as a reservoir of basic fibroblast growth factor. (2004) (116)
Accumulated allelic losses in the development of invasive urothelial cancer (1993) (116)
A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. (2006) (110)
Involvement of urinary bladder Connexin43 and the circadian clock in coordination of diurnal micturition rhythm (2012) (109)
Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese (2012) (107)
Secreted CXCL1 Is a Potential Mediator and Marker of the Tumor Invasion of Bladder Cancer (2008) (107)
Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan (2018) (105)
Overexpression of human mutT homologue gene messenger RNA in renal‐cell carcinoma: Evidence of persistent oxidative stress in cancer (1996) (103)
Induction of smooth muscle cell-like phenotype in marrow-derived cells among regenerating urinary bladder smooth muscle cells. (2005) (103)
Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification. (1994) (102)
Bladder regeneration by bladder acellular matrix combined with sustained release of exogenous growth factor. (2003) (97)
STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma. (2007) (96)
Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells (2004) (94)
Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism (2003) (93)
Clinical and molecular features of treatment‐related neuroendocrine prostate cancer (2018) (93)
Liver targeting of plasmid DNA by pullulan conjugation based on metal coordination. (2002) (91)
Distribution and genetic association of putative uropathogenic virulence factors iroN, iha, kpsMT, ompT and usp in Escherichia coli isolated from urinary tract infections in Japan. (2003) (89)
Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan. (2009) (88)
The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors. (2003) (88)
Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics. (2012) (88)
Human insulin-like growth factor type I and type II receptors are not imprinted. (1993) (87)
Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model. (2010) (86)
Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population. (2005) (83)
Prospective evaluation of selection criteria for active surveillance in Japanese patients with stage T1cN0M0 prostate cancer. (2008) (82)
Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation. (2008) (81)
Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma. (1991) (81)
Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer. (2006) (81)
Escherichia coli Isolates Associated with Uncomplicated and Complicated Cystitis and Asymptomatic Bacteriuria Possess Similar Phylogenies, Virulence Genes, and O-Serogroup Profiles (2006) (81)
Distinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumors. (2001) (79)
Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer (2008) (78)
Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin. (2000) (76)
Expression Levels of Renal Organic Anion Transporters (OATs) and Their Correlation with Anionic Drug Excretion in Patients with Renal Diseases (2004) (76)
Development of Japanese version of the UCLA Prostate Cancer Index: a pilot validation study (2002) (76)
Development of a Multiplex RNA Urine Test for the Detection and Stratification of Transitional Cell Carcinoma of the Bladder (2008) (75)
Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin. (2001) (73)
Increased Serum Levels of Vascular Endothelial Growth Factor in Patients with Renal Cell Carcinoma (1999) (73)
Current status of endocrine therapy for prostate cancer in Japan analysis of primary androgen deprivation therapy on the basis of data collected by J-CaP. (2007) (72)
Chronobiology of micturition: putative role of the circadian clock. (2013) (71)
Exposure–Toxicity Relationship of Sorafenib in Japanese Patients with Renal Cell Carcinoma and Hepatocellular Carcinoma (2014) (70)
Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma (2008) (70)
Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer (2001) (70)
Thioredoxin-interacting protein suppresses bladder carcinogenesis. (2011) (68)
176: Soluble Substances from Bladder Smooth Muscle Cells Induce Smooth Muscle Cell-Like Phenotype in Bone Marrow Stromal Cells (2004) (66)
Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population. (2003) (65)
Efficacy of nondrug lifestyle measures for the treatment of nocturia. (2010) (65)
Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein. (2006) (65)
Structural and sequence diversity of the pathogenicity island of uropathogenic Escherichia coli which encodes the USP protein. (2001) (62)
Allelic Frequency of p53 Gene Codon 72 Polymorphism in Urologic Cancers (1995) (61)
P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer. (2007) (60)
Septins as diagnostic markers for a subset of human asthenozoospermia. (2008) (59)
The presence of the virulence island containing the usp gene in uropathogenic Escherichia coli is associated with urinary tract infection in an experimental mouse model. (2001) (59)
The Expression Profile of Phosphatidylinositol in High Spatial Resolution Imaging Mass Spectrometry as a Potential Biomarker for Prostate Cancer (2014) (59)
Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer. (2003) (59)
Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of bladder transitional cell carcinoma to Cisplatin. (2008) (59)
Precise comparison of protein localization among OCT, OAT, and MATE in human kidney. (2013) (58)
Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer. (2002) (58)
Basic fibroblast growth factor modulates proliferation and collagen expression in urinary bladder smooth muscle cells. (2007) (57)
ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma. (2010) (57)
Efficient gene transfer by pullulan-spermine occurs through both clathrin- and raft/caveolae-dependent mechanisms. (2006) (57)
Patient-derived xenografts as in vivo models for research in urological malignancies (2017) (57)
Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer. (2000) (56)
Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis. (2004) (56)
Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP surveillance. (2004) (56)
Health related quality of life in Japanese men with localized prostate cancer treated with current multiple modalities assessed by a newly developed Japanese version of the Expanded Prostate Cancer Index Composite. (2007) (56)
Verotoxin induces rapid elimination of human renal tumor xenografts in SCID mice. (2004) (55)
Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications (2017) (54)
Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy. (2006) (54)
Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer (2015) (54)
Increased biofilm formation in Escherichia coli isolated from acute prostatitis. (2006) (53)
Allelic loss of chromosome 17p in urothelial cancer: strong association with invasive phenotype. (1992) (53)
Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy‐naïve castration‐resistant prostate cancer: The Kyoto‐Baltimore collaboration (2017) (52)
Ultrasound Enhancement of In Vitro Transfection of Plasmid DNA by a Cationized Gelatin (2002) (52)
Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10. (2003) (52)
Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan (2000) (52)
The importance of integrin‐linked kinase in the regulation of bladder cancer invasion (2012) (52)
Prevalence of skeletal complications and their impact on survival of hormone refractory prostate cancer patients in Japan. (2009) (51)
Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision (2020) (51)
A novel tumor‐related protein, C7orf24, identified by proteome differential display of bladder urothelial carcinoma (2007) (51)
Ultrasound enhances the transfection of plasmid DNA by non-viral vectors. (2003) (50)
Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines (2006) (50)
Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species. (2007) (50)
Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma. (2001) (50)
Single nucleotide polymorphisms in the 3' untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma. (2002) (49)
Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer (2013) (49)
TRAIL and chemotherapeutic drugs in cancer therapy. (2004) (49)
Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice. (2003) (49)
A phase III multicenter, randomized, controlled study of combined androgen blockade with versus without zoledronic acid in prostate cancer patients with metastatic bone disease: results of the ZAPCA trial (2017) (49)
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer (2019) (49)
Subtyping of uropathogenic Escherichia coli according to the pathogenicity island encoding uropathogenic‐specific protein: Comparison with phylogenetic groups (2006) (48)
Requirement of androgen-dependent activation of protein kinase Czeta for androgen-dependent cell proliferation in LNCaP Cells and its roles in transition to androgen-independent cells. (2006) (48)
CA repeat polymorphism in the insulin-like growth factor-I gene is associated with increased risk of prostate cancer and benign prostatic hyperplasia. (2005) (47)
Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population (2008) (47)
Prognostic significance of HIF‐1α polymorphisms in transitional cell carcinoma of the bladder (2008) (47)
Analysis of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidney (2008) (46)
The abnormal occurrence and the differentiation‐dependent distribution of N‐acetyl and N‐glycolyl species of the ganglioside GM2 in human germ cell tumors a study with specific monoclonal antibodies (1990) (46)
Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population. (2006) (46)
Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis model (2013) (46)
Plasma low-molecular-weight proteome profiling identified neuropeptide-Y as a prostate cancer biomarker polypeptide. (2013) (45)
Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients (2010) (45)
Enhancement of TRAIL/Apo2L‐mediated apoptosis by adriamycin through inducing DR4 and DR5 in renal cell carcinoma cells (2003) (45)
Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder. (2008) (45)
Seasonal alterations in nocturia and other storage symptoms in three Japanese communities. (2007) (45)
Association of genetic polymorphisms at 8q24 with the risk of prostate cancer in a Japanese population (2008) (45)
Expression of vascular endothelial growth factor gene and its receptor (flt-1) gene in urinary bladder cancer. (1998) (43)
Critical roles of Sp1 in gene expression of human and rat H+/organic cation antiporter MATE1. (2007) (43)
Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone (2019) (43)
Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan (1999) (42)
A functional variant in NKX3.1 associated with prostate cancer susceptibility down-regulates NKX3.1 expression. (2010) (42)
Methylation-associated silencing of SFRP1 in renal cell carcinoma. (2008) (42)
Basic fibroblast growth factor causes urinary bladder overactivity through gap junction generation in the smooth muscle. (2009) (42)
Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population. (2002) (41)
Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p. (1992) (41)
CCL2 as a potential therapeutic target for clear cell renal cell carcinoma (2016) (41)
Polymorphisms in prostate-specific antigen (PSA) gene, risk of prostate cancer, and serum PSA levels in Japanese population. (2003) (41)
Cloning of novel Wilms tumor gene (WT1) cDNAs; evidence for antisense transcription of WT1. (1994) (41)
Localization of tumor suppressor gene associated with distant metastasis of urinary bladder cancer to a 1‐Mb interval on 8p22 (1999) (41)
Distribution of the usp Gene in Uropathogenic Escherichia coli Isolated from Companion Animals and Correlation with Serotypes and Size‐Variations of the Pathogenicity Island (2003) (40)
Lansoprazole—Tacrolimus Interaction in Japanese Transplant Recipient with CYP2C19 Polymorphism (2004) (40)
Evaluation for Surrogacy of End Points by Using Data from Observational Studies: Tumor Downstaging for Evaluating Neoadjuvant Chemotherapy in Invasive Bladder Cancer (2006) (40)
Enhanced expression of plasmid DNA-cationized gelatin complex by ultrasound in murine muscle. (2002) (40)
Activation of Rac1 is closely related to androgen-independent cell proliferation of prostate cancer cells both in vitro and in vivo. (2010) (39)
Prognostic significance of HIF-1 alpha polymorphisms in transitional cell carcinoma of the bladder. (2008) (39)
Methylation-associated silencing of TU3A in human cancers. (2008) (39)
Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism (2018) (39)
Expression patterns of cancer testis antigens in testicular germ cell tumors and adjacent testicular tissue. (2001) (38)
Activation of caspase-3 in renal cell carcinoma cells by anthracyclines or 5-fluorouracil. (2001) (38)
Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan. (2014) (38)
Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab (2020) (38)
In Vitro Transfection of Plasmid DNA by Amine Derivatives of Gelatin Accompanied with Ultrasound Irradiation (2002) (38)
Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine. (2004) (37)
Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft (2010) (37)
12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population (2019) (37)
Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer (2013) (37)
Prognostic impact of extensive parenchymal invasion pattern in pT3 renal pelvic transitional cell carcinoma (2002) (37)
Laparoscopic partial nephrectomy using microwave tissue coagulator for small renal tumors: usefulness and complications. (2004) (36)
Influence of body mass index on prognosis of Japanese patients with renal cell carcinoma. (2007) (36)
Genome-wide analysis identifies a tumor suppressor role for aminoacylase 1 in iron-induced rat renal cell carcinoma. (2009) (35)
IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility. (2012) (35)
The Effect of ABCG2 Genotype on the Population Pharmacokinetics of Sunitinib in Patients With Renal Cell Carcinoma (2014) (35)
Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men (2007) (35)
Night‐time frequency, sleep disturbance and general health‐related quality of life: Is there a relation? (2009) (34)
Contribution of Chromosome 9p21‐22 Deletion to the Progression of Human Renal Cell Carcinoma (1995) (34)
Regulation of androgen receptor transactivity and mTOR–S6 kinase pathway by Rheb in prostate cancer cell proliferation (2010) (34)
High incidence of urinary bladder involvement in carcinomas of the sigmoid and rectum: A retrospective review of 580 patients with colorectal carcinoma (2003) (34)
Changing concepts of bladder regeneration (2007) (34)
Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer. (2019) (34)
Discrepancy between local and central pathological review of radical prostatectomy specimens. (2009) (34)
High 18F-fluorodeoxyglocose uptake in adrenal histoplasmosis; a case report (2005) (33)
Fluorescent imaging of high‐grade bladder cancer using a specific antagonist for chemokine receptor CXCR4 (2009) (33)
Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3β with p53 (2008) (33)
Defective Jak–Stat activation in renal cell carcinoma is associated with interferon‐α resistance (2007) (33)
A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome. (1993) (32)
Authentic role of ATP signaling in micturition reflex (2016) (32)
Microsatellite polymorphism of steroid hormone synthesis gene CYP11A1 is associated with advanced prostate cancer (2004) (32)
Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer. (2007) (32)
Assessment of a protocol for prophylactic antibiotics to prevent perioperative infection in urological surgery: A preliminary study (2004) (32)
Dicoumarol enhances doxorubicin‐induced cytotoxicity in p53 wild‐type urothelial cancer cells through p38 activation (2010) (31)
Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers (2003) (31)
Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival (2015) (31)
Reproducibility, Performance, and Clinical Utility of a Genetic Risk Prediction Model for Prostate Cancer in Japanese (2012) (31)
Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma. (1998) (31)
Genetic polymorphisms in glutathione S-transferase T1 affect the surgical outcome of varicocelectomies in infertile patients. (2009) (31)
Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (2015) (31)
Clinical evaluation of p53 mutations in urothelial carcinoma by IHC and FASAY. (2004) (30)
Common single nucleotide polymorphisms of the MDR1 gene have no influence on its mRNA expression level of normal kidney cortex and renal cell carcinoma in Japanese nephrectomized patients (2004) (30)
Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel. (2007) (30)
Distinct effects of omeprazole and rabeprazole on the tacrolimus blood concentration in a kidney transplant recipient. (2007) (30)
A Survey of the FAERS Database Concerning the Adverse Event Profiles of α1-Adrenoreceptor Blockers for Lower Urinary Tract Symptoms (2013) (30)
STAT3 polymorphism can predict the response to interferon-α therapy in patients with metastatic renal cell carcinoma. (2013) (30)
Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas (2003) (29)
[The Japanese translation and cultural adaptation of Expanded Prostate Cancer Index Composite (EPIC)]. (2005) (29)
Differences and associations between nocturnal voiding/nocturia and sleep disorders (2009) (29)
Differential control of allo-antigen-specific regulatory T cells and effector T cells by anti-CD4 and other agents in establishing transplantation tolerance. (2009) (29)
Low incidence of ipsilateral adrenal involvement and recurrences in patients with renal cell carcinoma undergoing radical nephrectomy: a retrospective analysis of 393 patients. (2003) (29)
Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney. (2007) (29)
Intravital imaging of mouse urothelium reveals activation of extracellular signal‐regulated kinase by stretch‐induced intravesical release of ATP (2016) (29)
Tumor targeting of gene expression through metal-coordinated conjugation with dextran. (2003) (29)
Molecular epidemiological evidence for ascending urethral infection in acute bacterial prostatitis. (2000) (28)
Association of common missense changes in ELAC2 (HPC2) with prostate cancer in a Japanese case-control series (2002) (27)
Prognostic criteria in patients with prostate cancer: Gleason score versus volume-weighted mean nuclear volume. (1997) (27)
RBM10–TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break‐apart fluorescence in‐situ hybridisation: study of 10 cases and a literature review (2019) (27)
Association of lipoprotein lipase gene polymorphism with risk of prostate cancer in a japanese population (2004) (26)
Perioperative Antimicrobial Prophylaxis in Urology: a Multi-Center Prospective Study (2005) (26)
The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE. (2006) (26)
An EP4 Antagonist ONO-AE3-208 Suppresses Cell Invasion, Migration, and Metastasis of Prostate Cancer (2014) (26)
Multipoint methylation and expression analysis of tumor suppressor genes in human renal cancer cells. (2003) (26)
Altered Detrusor Gap Junction Communications Induce Storage Symptoms in Bladder Inflammation: A Mouse Cyclophosphamide-Induced Model of Cystitis (2014) (26)
A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort (2016) (26)
Infrequent ras Mutation in Human Stomach Cancers (1993) (26)
Fabrication of an Optimal Urethral Graft Using Collagen-Sponge Tubes Reinforced with Copoly(L-Lactide/ε-Caprolactone) Fabric (2007) (25)
Comparison of the effectiveness of ET-Kyoto with Euro-Collins and University of Wisconsin solutions in cold renal storage (2002) (25)
Defective Jak-Stat activation in renal cell carcinoma is associated with interferon-alpha resistance. (2007) (25)
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies (2019) (25)
[A multi-center prospective study for antibiotic prophylaxis to prevent perioperative infections in urologic surgery]. (2004) (25)
p53 and chemosensitivity in bladder cancer (2008) (25)
Lectin-reactive α-Fetoprotein (AFP-L3%) Curability and Prediction of Clinical Course after Treatment of Non-seminomatous Germ Cell Tumors (2002) (25)
Analytical performance of a new automated chemiluminescent magnetic immunoassays for soluble PD-1, PD-L1, and CTLA-4 in human plasma (2019) (25)
Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: a case study (2010) (25)
Restoration of cyclin D2 has an inhibitory potential on the proliferation of LNCaP cells. (2009) (24)
CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese population. (2005) (24)
Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen. (2006) (24)
Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: intensity-modulated radiation therapy versus conformal radiation therapy (2007) (24)
Urine CXCL1 as a biomarker for tumor detection and outcome prediction in bladder cancer. (2015) (23)
Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers (2007) (23)
Long-term functional outcomes of ileal and sigmoid orthotopic neobladder procedures. (2006) (23)
Anaphylaxis following administration of intravenous methylprednisolone sodium succinate in a renal transplant recipient (2004) (23)
A transient increase of calcineurin phosphatase activity in living-donor kidney transplant recipients with acute rejection. (2010) (23)
Successful laparoscopic management of chylous ascites following laparoscopic radical nephrectomy (2006) (23)
B‐type natriuretic peptide as an independent correlate of nocturnal voiding in Japanese women (2012) (23)
Survival of metastatic germ cell cancer patients assessed by international germ cell consensus classification in Japan. (2008) (23)
SPA‐1 controls the invasion and metastasis of human prostate cancer (2011) (23)
An Accessory Spleen Mimicking a Nonfunctional Adrenal Tumor: A Potential Pitfall in the Diagnosis of a Left Adrenal Tumor (2000) (22)
Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology (2019) (22)
A potent chemotherapeutic strategy in prostate cancer: S-(methoxytrityl)-L-cysteine, a novel Eg5 inhibitor. (2011) (22)
Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era. (2013) (21)
Medical mushrooms used for biochemical failure after radical treatment for prostate cancer: An open‐label study (2010) (21)
GSTT1 and GSTM1 polymorphisms are associated with improvement in seminal findings after varicocelectomy. (2005) (21)
Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges (2018) (21)
Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A (2017) (21)
Evidence‐based clinical practice guidelines for bladder cancer (Summary – JUA 2009 Edition) (2010) (21)
Sleep Disturbance Worsens Lower Urinary Tract Symptoms: The Nagahama Study. (2019) (20)
Regulation of connexin 43 by basic fibroblast growth factor in the bladder: transcriptional and behavioral implications. (2011) (20)
Factors predicting efficacy and adverse effects of enzalutamide in Japanese patients with castration-resistant prostate cancer: results of retrospective multi-institutional study (2016) (20)
Immunohistochemical analysis of p53 and proliferating cell nuclear antigen (PCNA) in bladder cancer: positive immunostaining and radiosensitivity. (1995) (20)
Detection of alpha-fetoprotein mRNA in seminoma. (1999) (20)
Telomerase activity in adrenal cortical tumors and pheochromocytomas with reference to clinicopathologic features (1998) (20)
A genetic polymorphism of the osteoprotegerin gene is associated with an increased risk of advanced prostate cancer (2008) (20)
Elevation of serum transforming growth factor-β1 Level in patients with metastatic prostate cancer. (1996) (19)
The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan (2004) (19)
Antibiotic prophylaxis for transrectal prostate biopsy: A prospective randomized study of tosufloxacin versus levofloxacin (2008) (19)
JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma (2012) (19)
Surgical treatment for urethral recurrence after ileal neobladder reconstruction in patients with bladder cancer (2006) (19)
The novel tumor‐suppressor Mel‐18 in prostate cancer: Its functional polymorphism, expression and clinical significance (2009) (19)
Circadian coordination of ATP release in the urothelium via connexin43 hemichannels (2018) (19)
‘Trifecta’ outcomes of robot-assisted partial nephrectomy: a large Japanese multicenter study (2019) (19)
Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community‐based multi‐institutional database across Japan using propensity score matching (2018) (19)
Percentage of positive biopsy cores, preoperative prostate‐specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi‐institutional outcome study in Japan (2006) (19)
Association of a genetic polymorphism of the E-cadherin gene with prostate cancer in a Japanese population. (2005) (19)
A potent chemotherapeutic strategy for bladder cancer: (S)-methoxy-trityl-L-cystein, a novel Eg5 inhibitor. (2010) (19)
Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer. (2004) (19)
Two Target Regions of Allelic Loss on Chromosome 9 in Urinary‐bladder Cancer (1999) (18)
Constitutive activation of the 41‐ and 43‐kDa mitogen‐activated protein (MAP) kinases in the progression of prostate cancer to an androgen‐independent state (2005) (18)
Association of the cyclin D1 gene G870A polymorphism with susceptibility to sporadic renal cell carcinoma. (2004) (18)
The expression of NOV and WT1 in renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis. (2005) (18)
Non‐secretor status is associated with female acute uncomplicated pyelonephritis (2002) (18)
Equivalent Parental Distribution of Frequently Lost Alleles and Biallelic Expression of the H19 Gene in Human Testicular Germ Cell Tumors (1996) (18)
Clinical Practice Guidelines for Bladder Cancer 2019 edition by the Japanese Urological Association: Revision working position paper (2020) (18)
Antimicrobial prophylaxis to prevent perioperative infection in urological surgery: a multicenter study (2013) (18)
Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer (2018) (17)
Cross‐Sectional Epidemiological Analysis of the Nagahama Study for Correlates of Overactive Bladder: Genetic and Environmental Considerations (2017) (17)
Complications and reoperations after laparoscopic radical cystectomy in a Japanese multicenter cohort (2019) (17)
Reduced-dose docetaxel for castration-resistant prostate cancer has no inferior impact on overall survival in Japanese patients (2013) (17)
No association between HER‐2 gene polymorphism at codon 655 and a risk of bladder cancer (2002) (17)
Circulating prostate-specific antigen mRNA during radical prostatectomy in patients with localized prostate cancer: with special reference to neoadjuvant hormonal therapy (1999) (17)
Testicular thecoma in an 11-year-old boy with nevoid basal-cell carcinoma syndrome (Gorlin syndrome). (2010) (17)
Epithelial stromal tumor of the seminal vesicle (2006) (17)
High-resolution HLA-DRB1 and DQB1 genotyping in Japanese patients with testicular germ cell carcinoma. (1997) (17)
Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation (2007) (17)
Objective patterning of uroflowmetry curves in children with daytime and nighttime wetting. (2010) (17)
Role of mammalian target of rapamycin inhibitor in the treatment of metastatic epithelioid angiomyolipoma: A case report (2013) (17)
Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis (2013) (16)
In vitro transfection of plasmid DNA by different-cationized gelatin with or without ultrasound irradiation (2001) (16)
Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples (2016) (16)
Antiemetic efficacy and safety of a combination of palonosetron, aprepitant, and dexamethasone in patients with testicular germ cell tumor receiving 5-day cisplatin-based combination chemotherapy (2014) (16)
Role of Rev‐erbα domains for transactivation of the connexin43 promoter with Sp1 (2013) (16)
Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer (2011) (16)
Overexpression of ETS-1 is associated with malignant biological features of prostate cancer. (2012) (16)
Up‐regulation of miR‐582‐5p regulates cellular proliferation of prostate cancer cells under androgen‐deprived conditions (2014) (15)
Clinical significance of a single nucleotide polymorphism and allelic imbalance of matrix metalloproteinase-1 promoter region in prostate cancer. (2009) (15)
Association of XRCC1 gene polymorphisms with the susceptibility and chromosomal aberration of testicular germ cell tumors. (2006) (15)
A genome-wide association study of serum levels of prostate-specific antigen in the Japanese population (2014) (15)
Distribution of afaE adhesins in Escherichia coli isolated from Japanese patients with urinary tract infection. (2003) (15)
Tumor microvasculature with endothelial fenestrations in VHL null clear cell renal cell carcinomas as a potent target of anti‐angiogenic therapy (2012) (15)
Development of diurnal micturition pattern in mice after weaning. (2013) (15)
The Transcription Factor Sp3 Regulates the Expression of a Metastasis-Related Marker of Sarcoma, Actin Filament-Associated Protein 1-Like 1 (AFAP1L1) (2013) (15)
697O A phase III, randomized, open-label study of first-line durvalumab (D) with or without tremelimumab (T) vs standard of care chemotherapy in patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE) (2020) (15)
Failure of ureteric bud invasion: a new model of renal agenesis in mice. (2001) (15)
Correlation of initial PSA level and biopsy features with PSA-doubling time in early stage prostate cancers in Japanese men. (2002) (15)
Prevalence of postmicturition urinary incontinence in Japanese men: Comparison with other types of incontinence (2013) (14)
Per‐operative frozen section examination of pelvic nodes is unnecessary for the majority of clinically localized prostate cancers in the prostate‐specific antigen era (2000) (14)
Age‐associated increase of prostate‐specific antigen in a high level of men visiting urological clinics (2005) (14)
[Effects of ischemia on voiding function and nerve growth factor of the rat urinary bladder]. (1999) (14)
Bowel perforation by a peritoneal dialysis catheter: report of two cases (2017) (14)
The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients (2019) (14)
Amino‐terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer (2017) (14)
Prostate specific antigen nadir determined using ultra‐sensitive prostate specific antigen as a predictor of biochemical progression after radical prostatectomy in Japanese males (2007) (14)
Definition of a 1-Mb homozygous deletion at 9q32-q33 in a human bladder-cancer cell line (2001) (14)
Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR (2021) (14)
Comparative evaluation of the extraction and analysis of urinary phospholipids and lysophospholipids using MALDI-TOF/MS. (2019) (14)
Impact of Nocturia on Mortality: The Nagahama Study. (2020) (14)
Clinical significance of polymorphism and expression of chromogranin a and endothelin-1 in prostate cancer. (2010) (14)
RECENT ADVANCES IN THE MOLECULAR GENETICS OF UROGENITAL TUMORS (1994) (13)
Significance of elevated preoperative α‐fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors (2006) (13)
The C-Terminal Fragment of Prostate-Specific Antigen, a 2331 Da Peptide, as a New Urinary Pathognomonic Biomarker Candidate for Diagnosing Prostate Cancer (2014) (13)
Longitudinal Analysis of Bidirectional Relationships Between Nocturia and Depressive Symptoms: The Nagahama Study. (2019) (13)
Development and external validation of a preoperative nomogram for predicting pathological locally advanced disease of clinically localized upper urinary tract carcinoma (2020) (13)
Nucleotide variations in genes encoding plasminogen activator inhibitor-2 and serine proteinase inhibitor B10 associated with prostate cancer (2005) (13)
[Small cell carcinoma of the bladder]. (2014) (13)
Association of the PIG3 promoter polymorphism with invasive bladder cancer in a Japanese population. (2006) (12)
Clinical implications of the MDM 2 SNP 309 and p 53 Arg 72 Pro polymorphisms in transitional cell carcinoma of the bladder (12)
Impact of the objective response to and number of cycles of platinum‐based first‐line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab (2021) (12)
Genomic characterization of multiple clinical phenotypes of cancer using multivariate linear regression models (2007) (12)
Good prognosis of cellular mesoblastic nephroma with hyperdiploidy and relaxation of imprinting of the maternal IGF2 gene. (1995) (12)
MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway. (2015) (12)
A multi-center study of pediatric uroflowmetry data using patterning software. (2013) (11)
Laparoscopic Adrenalectomy for Bilateral Pheochromocytoma: A Case Report (1997) (11)
Differences between bothersome and non‐bothersome night‐time frequency (2007) (11)
Downregulation of RalGTPase-activating protein promotes invasion of prostatic epithelial cells and progression from intraepithelial neoplasia to cancer during prostate carcinogenesis. (2019) (11)
Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort (2021) (11)
Population Pharmacokinetics of Everolimus in Relation to Clinical Outcomes in Patients With Advanced Renal Cell Carcinoma (2016) (11)
Perioperative and oncological outcomes of laparoscopic radical cystectomy with intracorporeal versus extracorporeal ileal conduit: A matched‐pair comparison in a multicenter cohort in Japan (2020) (11)
Atypical true hermaphroditism with a mosaic 45,X/46,X,dic(Y) (q11.2) karyotype. (1998) (11)
Monthly paclitaxel and carboplatin with oral estramustine phosphate in patients with hormone-refractory prostate cancer (2005) (11)
CXCL1 is elevated in the urine of bladder cancer patients (2015) (11)
Distinct cancer-specific survival in metastatic prostate cancer patients classified by a panel of single nucleotide polymorphisms of cancer-associated genes. (2013) (11)
5‐year interval change in voiding function of orthotopic ileal neobladder (2006) (11)
Long-term outcomes of intensity-modulated radiation therapy combined with neoadjuvant androgen deprivation therapy under an early salvage policy for patients with T3-T4N0M0 prostate cancer (2016) (11)
Risk factors for loss to follow-up during active surveillance of patients with Stage I seminoma. (2014) (11)
Risk factors predicting the outcome of salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy (2013) (11)
[National trend of management of benign prostatic hyperplasia in Japan during 1990s: analysis of national health statistics]. (2000) (11)
Fabrication of an optimal urethral graft using collagen-sponge tubes reinforced with Copoly(L-lactide/epsilon-caprolactone) fabric. (2007) (11)
Docetaxel‐based chemotherapy combined with dexamethasone 1 mg daily oral administration for castration‐resistant prostate cancer: Long‐term outcomes (2019) (10)
The efficacy and safety of docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration: JMTO Pca 10-01 phase II trial (2017) (10)
Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors. (2002) (10)
BCL10 is not a major target for frequent loss of 1p in testicular germ cell tumors. (2001) (10)
Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation (2019) (10)
BALB/c-Fcgr2b−/−Pdcd1−/− mouse expressing anti-urothelial antibody is a novel model of autoimmune cystitis (2012) (10)
Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma. (2019) (10)
Increased intracellular doxorubicin by anti-FAS monoclonal antibody: a mechanism that enhances the cytotoxicity in renal cell carcinoma cells. (2001) (10)
Consecutive Prostate Cancer Specimens Revealed Increased Aldo–Keto Reductase Family 1 Member C3 Expression with Progression to Castration-Resistant Prostate Cancer (2019) (10)
PTHrP is endogenous relaxant for spontaneous smooth muscle contraction in urinary bladder of female rat. (2013) (10)
Follow‐up of clinical stage I testicular cancer patients: Cost and risk benefit considerations (2002) (10)
Decision Analysis for Treatment of Early Stage Prostate Cancer (1998) (10)
Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan (2013) (10)
An original patient‐derived xenograft of prostate cancer with cyst formation (2016) (10)
Laparoendoscopic single-site surgery for left adrenalectomy: standardization of technique. (2011) (10)
Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort (2020) (10)
Predictive value of radiological response rate for pathological response to neoadjuvant chemotherapy and post-cystectomy survival of bladder urothelial cancer. (2016) (10)
Effective and Safe Administration of Low-Dose Estramustine Phosphate for Castration-Resistant Prostate Cancer. (2016) (10)
Urinary Protein Markers for the Detection and Prognostication of Urothelial Carcinoma. (2018) (9)
Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma (2019) (9)
Roles of androgen-dependent and -independent activation of signal transduction pathways for cell proliferation of prostate cancer cells (2007) (9)
Furosemide versus Gosha‐Jinki‐Gan, a Blended Herbal Medicine, for Nocturnal Polyuria: A Randomized Crossover Trial (2012) (9)
Augmented Reality Navigation System for Robot-Assisted Laparoscopic Partial Nephrectomy (2017) (9)
Purine‐rich element binding protein (PUR) α induces endoplasmic reticulum stress response, and cell differentiation pathways in prostate cancer cells (2009) (9)
Retroperitoneoscopic treatment of caliceal diverticular calculi: report of two cases and review of the literature. (2004) (9)
Clinical evaluation of serum p53 antibodies in patients with upper urinary tract tumors. (2005) (9)
CCL 2 as a potential therapeutic target for clear cell renal cell carcinoma (2019) (9)
Semi-quantitative analysis of telomerase activity of exfoliated cells in urine of patients with urothelial cancers: Causative factors affecting sensitivity and specificity. (1997) (9)
Gliding Basal Cell Migration of the Urothelium during Wound Healing. (2018) (9)
Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance (2018) (9)
Sequential Use of Androgen Receptor Axis-targeted Agents in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Retrospective Analysis With 3-Year Follow-up. (2019) (9)
Clinical Significance of Varicocelectomy for Male Infertility (2000) (9)
Clinical Impact of Detecting Low-Frequency Variants in Cell-Free DNA on Treatment of Castration-Resistant Prostate Cancer (2021) (9)
Clinical Significance of Nonpalpable Prostate Cancer with Favorable Biopsy Features in Japanese Men (2000) (9)
Laser-capture microdissection for analysis of cell type-specific gene expression of muscarinic receptor subtypes in the rat bladder with cyclophosphamide-induced cystitis (2015) (9)
Recovery of Serum Testosterone Levels and Sexual Function in Patients Treated With Short‐term Luteinizing Hormone‐releasing Hormone Antagonist as a Neoadjuvant Therapy Before External Radiotherapy for Intermediate‐risk Prostate Cancer: Preliminary Prospective Study (2017) (9)
University of California at Los Angeles Prostate Cancer Index (UCLA PCI) 日本語版作成の試み (2002) (9)
Urethral mobility at catheter removal predicts early recovery of urinary continence after radical prostatectomy (2009) (9)
Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c-T2N0M0 prostate cancer (2016) (8)
Underweight body mass index is a risk factor of mortality in outpatients with nocturia in Japan (2015) (8)
High level of phosphatidylcholines/lysophosphatidylcholine ratio in urine is associated with prostate cancer (2021) (8)
Asia prostate cancer study (A-CaP Study) launch symposium (2016) (8)
Feasibility of laparoscopic adrenalectomy for metastatic adrenal tumors in selected patients: a retrospective multicenter study of Japanese populations (2019) (8)
The clinical utility of measuring total PSA, PSA density, gamma-seminoprotein and gamma-seminoprotein/total PSA in prostate cancer prediction. (2000) (8)
Prognosis of metastatic renal cell carcinoma with first‐line interferon‐α therapy in the era of molecular‐targeted therapy (2016) (8)
Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan (2019) (8)
A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer (2016) (8)
Cytotoxic T Lymphocytes Regenerated from iPS Cells Have Therapeutic Efficacy in a Patient-Derived Xenograft Solid Tumor Model (2020) (8)
Dietary Sodium Restriction Reduces Nocturnal Urine Volume and Nocturnal Polyuria Index in Renal Allograft Recipients With Nocturnal Polyuria. (2017) (8)
A phase III, randomized, open-label, multicenter, global study of first-line durvalumab plus standard of care (SoC) chemotherapy and durvalumab plus tremelimumab, and SoC chemotherapy versus SoC chemotherapy alone in unresectable locally advanced or metastatic urothelial cancer (NILE). (2021) (8)
Evaluation of quantitative parameters for distinguishing pheochromocytoma from other adrenal tumors (2018) (8)
Improvement of prognosis in patients with metastatic renal cell carcinoma and Memorial Sloan-Kettering Cancer Center intermediate risk features by modern strategy including molecular-targeted therapy in clinical practice (2013) (8)
Synergy of interferon-alpha and 5-fluorouracil in human renal cell carcinoma requires p53 activity. (2007) (8)
Synergy of Interferon-α and 5-Fluorouracil in Human Renal Cell Carcinoma Requires p53 Activity (2007) (7)
A case of primary urethral lymphoma presenting as a huge mass surrounding the female urethra. (1997) (7)
Effect of optimal neoadjuvant chemotherapy on oncological outcomes of locally advanced bladder cancer with laparoscopic radical cystectomy: A matched‐pair analysis in a multicenter cohort (2021) (7)
Large scale genome-wide association study in a Japanese population identified 45 novel susceptibility loci for 22 diseases (2019) (7)
Late recurrence of nonseminomatous germ cell tumor successfully treated with intensity-modulated radiation therapy. (2013) (7)
High incidence of BK virus‐associated hemorrhagic cystitis in children after second or third allogeneic hematopoietic stem cell transplantation (2018) (7)
Molecular diagnosis of metastatic origin in a patient with metachronous multiple cancers of the renal pelvis and bladder. (2000) (7)
Efficacy and Safety of Carboplatin Plus Paclitaxel as the First-, Second-, and Third-line Chemotherapy in Men With Castration-resistant Prostate Cancer. (2019) (7)
Renal scarring is associated with nonsecretion of blood type antigen in children with primary vesicoureteral reflux. (2005) (7)
Detectability of prostate cancer in different parts of the gland with 3-Tesla multiparametric magnetic resonance imaging: correlation with whole-mount histopathology (2019) (7)
A polymorphism of the POLG2 gene is genetically associated with the invasiveness of urinary bladder cancer in Japanese males (2011) (7)
The Clinical Utility of Measuring Total PSA , PSA Density , γ-Seminoprotein and γ-Seminoprotein / Total PSA in Prostate Cancer Prediction (2000) (7)
The Short-Term Impact of Dietary Counseling on Sodium Intake and Blood Pressure in Renal Allograft Recipients (2016) (6)
Retroperitoneoscopic ureterocalicostomy for congenital proximal ureteral stenosis. (2004) (6)
SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization (2021) (6)
A family case with germline TSC1 and mtDNA mutations developing bilateral eosinophilic chromophobe renal cell carcinomas without other typical phenotype of tuberous sclerosis (2018) (6)
The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancer (2021) (6)
eVIDENCE: a practical variant filtering for low-frequency variants detection in cell-free DNA (2019) (6)
[A case of myxoid liposarcoma in the right inguinal region: a case report]. (2006) (6)
Trp53 mutation in Krt5-expressing basal cells facilitates the development of basal squamous-like invasive bladder cancer in the chemical carcinogenesis of mouse bladder. (2020) (6)
Adult‐onset idiopathic hypogonadotropic hypogonadism presented with erectile and ejaculatory disorder (2002) (6)
High incidence of urological complications in men dying from prostate cancer (2016) (6)
Initial evaluation of PET/CT with 18F‐FSU‐880 targeting prostate‐specific membrane antigen in prostate cancer patients (2019) (6)
Ratio of prostate specific antigen minor molecular forms-to-total prostate specific antigen is constant regardless of the pathological condition of the prostate. (2003) (6)
Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score (2013) (6)
Establishment and characterization of a novel treatment‐related neuroendocrine prostate cancer cell line KUCaP13 (2021) (6)
Outcomes of curative nephrectomy against renal cell carcinoma based on a central pathological review of 914 specimens from the era of cytokine treatment (2015) (6)
Detection of von Hippel‐Lindau gene mutation in circulating cell‐free DNA for clear cell renal cell carcinoma (2021) (6)
Evaluation of predictors of unfavorable pathological features in men eligible for active surveillance using radical prostatectomy specimens: a multi-institutional study. (2016) (6)
Management of concomitant ureteral carcinoma in situ at radical cystectomy (2006) (6)
Immunocytochemical Detection of p53 in Cultures of Exfoliated Cells from Urine of Patients with Urothelial Cancers (1996) (6)
Narrative review of challenges in the management of advanced neuroendocrine prostate cancer (2021) (6)
[Translation and adaptation of the UCLA prostate cancer index for use in Japan]. (2002) (6)
Incidence of adrenal involvement and assessing adrenal function in patients with renal cell carcinoma: is ipsilateral adrenalectomy indispensable during radical nephrectomy? (2005) (6)
LacdiNAc-Glycosylated Prostate-specific Antigen Density is a Potential Biomarker of Prostate Cancer. (2019) (6)
First report of idiopathic segmental ureteritis successfully treated by steroid therapy (2012) (6)
Preoperative diagnosis of congenital segmental giant megaureter presenting as a fetal abdominal mass. (2010) (6)
Evaluation of Calvert's formula for dosage adjustment of carboplatin in Japanese patients with hormone refractory prostate cancer. (2006) (6)
Retroperitoneoscopic ureterocutaneostomy for obstructive uropathy with advanced bladder cancer: A case report (2002) (5)
High throughput comparative genomic hybridization array analysis of multifocal urothelial cancers (2006) (5)
Successful treatment of primary aldosteronism due to computed tomography‐negative microadenoma (2003) (5)
High throughput comparative genomic hybridization array analysis of multifocal urothelial cancers. (2006) (5)
[Clinical Characteristics of Prostate Ductal Adenocarcinoma in Kyoto University Hospital]. (2015) (5)
Low incidence of late recurrence in patients with intermediate-risk prostate cancer treated by intensity-modulated radiation therapy plus short-term androgen deprivation therapy (2019) (5)
TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer (2019) (5)
Expression of parathyroid hormone/parathyroid hormone-related peptide receptor 1 in normal and diseased bladder detrusor muscles: a clinico-pathological study (2015) (5)
Results of radiation therapy combined with neoadjuvant hormonal therapy for stage III prostate cancer: comparison of two different definitions of PSA failure (2006) (5)
[A case of malignant fibrous histiocytoma arising from the renal capsule]. (2001) (5)
The 2nd conference on Asian trends in prostate cancer hormone therapy. (2003) (5)
[Bilateral maxillary sinus metastasis of renal cell carcinoma: a case report]. (2007) (5)
Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching. (2021) (5)
[A case of vaginal metastasis of transitional cell carcinoma]. (2004) (5)
[Well-differentiated inflammatory liposarcoma occurring in the scrotum: a case report]. (2006) (5)
Clinical feasibility and acceptability of adding cognitive behavioral therapy to pharmacotherapy for drug‐resistant overactive bladder in women: A single‐arm pilot study (2020) (4)
Solitary upper ureteral malakoplakia successfully diagnosed by ureteroscopic biopsy and treated conservatively (2007) (4)
Medical history of nocturnal enuresis during school age is an independent risk factor for nocturia in adults: The Nagahama study (2020) (4)
Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy for Japanese patients with T1c-T2N0M0 prostate cancer (2010) (4)
Development of Japanese Version of the UCLA Prostate Cancer Index (2002) (4)
[Sperm cryopreservation for cancer patients: 5-year experience in a private hospital in Japan]. (2009) (4)
Protocol consisting of cisplatin, etoposide and irinotecan induced complete pathological remission of primary small cell carcinoma of the bladder (2006) (4)
[Solitary fibrous tumor in the pelvic space: a case report]. (2007) (4)
Association of XRCC 1 gene polymorphisms with the susceptibility and chromosomal aberration of testicular germ cell tumors (4)
Low bladder capacity is an important predictor for comorbidity of interstitial cystitis with Hunner's lesion in patients with refractory chronic prostatitis/chronic pelvic pain syndrome (2017) (4)
[One year follow-up results of urinary incontinence and sexual function after holmium laser enucleation of the prostate]. (2009) (4)
Association of BCL10 germ line polymorphisms on chromosome 1p with advanced stage testicular germ cell tumor patients. (2006) (4)
Subclassification of high-risk clinically organ-confined prostate cancer for early cancer-specific mortality after radical prostatectomy. (2016) (4)
The 3rd Conference on Asian Trends in Prostate Cancer Hormone Therapy. (2004) (4)
Add‐on effects of tadalafil in tamsulosin‐treated patients with small benign prostatic enlargement: A randomized, placebo‐controlled, double‐blind, crossover study (2020) (4)
Cognitive behavioral therapy for overactive bladder in women: study protocol for a randomized controlled trial (2020) (4)
[A case of ureteral malignant lymphoma with concentric thickening of the ureteral wall]. (2012) (4)
[Prostate cancer with penile metastasis: a case report]. (2005) (4)
Urothelium-Specific Deletion of Connexin43 in the Mouse Urinary Bladder Alters Distension-Induced ATP Release and Voiding Behavior (2021) (4)
Laparoscopic radical cystectomy in octogenarians: analysis of a Japanese multicenter cohort (2019) (4)
Sonodynamic Effect of Polyethylene glycol-conjugated Fullerene on Tumor (2002) (4)
Successful renal transplantation for end‐stage renal insufficiency developed in a patient with Castleman's disease (2013) (4)
Telomerase activity in urine after transurethral resection is not a predictive marker for recurrence of superficial bladder cancer (2003) (4)
Efficacy of Immediate Postoperative Instillation of Chemotherapy for Primary Non-Muscle-Invasive Bladder Cancer in Real-World Clinical Practice. (2019) (4)
A phase III, multicenter, randomized, controlled study of maximum androgen blockade with versus without zoledronic acid in treatment-naïve prostate cancer patients with bone metastases: Results of ZAPCA study. (2015) (4)
High‐grade and hormone‐treated prostate cancer express high levels of thymidylate synthase (2006) (4)
[Pseudomyxoma peritonei arising from urachal carcinoma]. (2013) (3)
[Usefulness of ultrasound-guided prostate biopsy in the diagnosis and treatment of localized prostate cancer]. (1996) (3)
ANDROGEN RECEPTOR GENE ABERRATIONS IN CIRCULATING CELL FREE DNA FROM JAPANESE CASTRATION RESISTANT PROSTATE CANCER PATIENTS: MP29‐05 (2018) (3)
Cavernous Nerve Graft Reconstruction with a Novel Artificial Conduit during Robot-Assisted Laparoscopic Radical Prostatectomy (2015) (3)
The effect of gemcitabine/paclitaxel chemotherapy on the survival of patients with metastatic urothelial cancers (2013) (3)
Three‐dimensional simulation analysis of microdissection testicular sperm extraction for patients with non‐obstructive azoospermia (2020) (3)
Data processing on a comparative evaluation of the extraction and analysis procedures for urinary phospholipid and lysophospholipid using MALDI-TOF/MS (2019) (3)
[Epidemiological survey of sexually transmitted male urethritis in Kyoto Prefecture]. (2006) (3)
Sensitization of human renal cell carcinoma cell lines to TRAIL‐induced apoptosis by anthracyclines (2004) (3)
[Cross-cultural validated adaptation of dysfunctional voiding symptom score (DVSS) to Japanese language and cognitive linguistics in questionnaire for pediatric patients]. (2014) (3)
Long-term outcomes of definitive external-beam radiotherapy for non-metastatic castration-resistant prostate cancer (2018) (3)
[Testicular Leydig cell tumor presenting as male infertility: a case report]. (2009) (3)
[Disruption of genomic imprinting in human carcinogenesis]. (1996) (3)
Adult wilms tumor in the renal pelvis: case report with review of the literature. (2008) (3)
329 ERG ONCOPROTEIN EXPRESSION IN LOCALIZED PROSTATE CANCER IN JAPANESE POPULATION (2012) (3)
[Marked improvement of cardiac function following renal transplantation: a case report]. (2003) (3)
[Retroperitoneal ganglioneuroma presenting as a soft tissue mass surrounding the aorta: report of a case]. (2005) (3)
[A Case of Late Onset Nivolumab-Induced Interstitial Nephritis in a Patient with Metastatic Renal Cell Carcinoma]. (2019) (3)
Long-term outcomes of dynamic conformal arc irradiation combined with neoadjuvant hormonal therapy in Japanese patients with T1c-T2N0M0 prostate cancer: case series study. (2014) (3)
Sperm cryopreservation: Clinical and fertility outcomes in male oncological patients with germ cell tumors or hematological disorders (2018) (3)
Increased risk of disease progression in younger men: Analysis of factors predicting biochemical failure and castration-resistant prostate cancer after high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer. (2020) (3)
[The role of ATP-receptor in controlling the urinary bladder and urethral function in rats]. (1999) (3)
The MET proto-oncogene is not a major target for the gain of chromosome 7 in testicular germ-cell tumors of adolescents (2004) (3)
285TiP DANUBE: A Phase 3 randomised study of first-line durvalumab (MEDI4736) ± tremelimumab vs standard of care (SoC) chemotherapy (CT) in patients (pts) with Stage IV urothelial carcinoma (UC) (2016) (3)
Late relapse of testicular cancer 21 years after first complete remission: a case report. (2008) (3)
Intravesical prostatic protrusion is not always the same shape: Evaluation by preoperative cystoscopy and outcome in HoLEP (2018) (3)
Rapid semen identification from mixed body fluids using methylation-sensitive high-resolution melting analysis of the DACT1 gene. (2020) (3)
[Impact of different methods of estimating renal function on determining eligibility for cisplatin (CDDP)-based chemotherapy in patients with invasive urothelial carcinoma]. (2011) (3)
Evaluation of the Quality of Life and Health-Related Quality of Life of Patients With End-Stage Kidney Disease Resulting From Kidney Transplantation Using the Kidney Disease Quality of Life-Short Form and EuroQOL-5 Dimension-5 Level Questionnaires. (2020) (3)
[Ultrasound-guided renal cyst puncture and 95% ethanol instillation. Part 2: Morphological and functional alterations]. (1984) (3)
Functional and genomic characterization of patient‐derived xenograft model to study the adaptation to mTORC1 inhibitor in clear cell renal cell carcinoma (2020) (3)
Guideline Adherence of Immediate Post‐Transurethral Resection Intravesical Chemotherapy for Patients with Nonmuscle Invasive Bladder Cancer (2016) (3)
Development of a Novel Tool for Assessing Deformation and Hardness of Real Organs: Pressure Measuring Grasper (PMEG) (2016) (3)
Long-term clinical outcomes of salvage pelvic radiation therapy for oligo-recurrent pelvic lymph nodes after definitive external-beam radiation therapy for non-metastatic prostate cancer (2020) (3)
Impact of a robotic surgical system on treatment choice for men with clinically organ-confined prostate cancer (2018) (3)
Modification of Platinum-based Systemic Chemotherapy for Advanced Urothelial Carcinoma in Patients With Suboptimal Renal Function (2021) (3)
Retroperitoneoscopic nephrectomy as a second-line treatment after transarterial embolization for symptomatic autosomal dominant polycystic kidney disease. (2006) (3)
[A Case of Thyroid-Like Follicular Carcinoma of the Kidney]. (2017) (3)
[Indication of varicocelectomy for the treatment of male infertility]. (2004) (2)
A functional variant in NKX 3 . 1 associated with prostate cancer susceptibility down-regulates NKX 3 . 1 expression (2010) (2)
[Post-operative recurrence patterns of urothelial tumors in the upper urinary tract: comparison between renal pelvic and ureteral tumors]. (2008) (2)
Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy in Japanese patients with locally advanced prostate cancer (2010) (2)
Outcomes of High-Dose Whole-Pelvic IMRT With Simultaneous Integrated Boost in Patients With Pelvic Lymph Node–Positive Prostate Cancer (2015) (2)
Enhancement of transduction efficiency using Adeno-associated viral vectors by chemical pretreatment to mice bladder urothelium. (2020) (2)
A pilot study of highly hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer (2018) (2)
Association of vitamin D receptor gene polymorphism with protection against prostate cancer and benign prostate hyperplasia (1999) (2)
[Multiple chromophobe renal cell carcinoma: a case report]. (2010) (2)
Current topics and perspectives in bladder cancer research (2008) (2)
Image Overlay Support with 3DCG Organ Model for Robot-Assisted Laparoscopic Partial Nephrectomy (2016) (2)
GENETIC PROFILES OF FLUOROQUINOLONE-RESISTANT ESCHERICHIA COLI ISOLATED FROM CYSTITIS: PHYLOGENY, VIRULENCE, PAIUSP-SUBTYPES, AND MUTATION PATTERNS (2009) (2)
Re: Comprehensive Molecular Characterization of Muscle-invasive Bladder Cancer. (2017) (2)
[Advanced Adenocarcinoma of the Bladder after Augmentation Gastrocystoplasty]. (2016) (2)
[Human prostatic tissue specific antigens: a model for the research of monoclonal antibodies against unknown antigens]. (1993) (2)
[Novel treatment for prostate cancer targeting prostaglandins]. (2014) (2)
[Questionnaire survey in Japan for sperm cryopreservation before chemotherapy ]. (2008) (2)
197: Prostate Cancer Screening Strategies with Rescreening Interval Determined by Individual Baseline Prostate-Specific Antigen Values are Cost-Effective (2007) (2)
Transition in Type of Surgery for Benign Prostatic Hyperplasia: A Multi‐institutional Study in Japan (2011) (2)
Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy (2022) (2)
[A case of renal subcapsular cyst successfully treated with endoscopic ultrasound-guided transgastric drainage of pancreatic pseudocyst]. (2012) (2)
The NOD/Shi-scid/IL-2Rγnull mice xenograft model recapitulates anaplastic large cell lymphoma dissemination to the bladder (2015) (2)
Long-term outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for Japanese patients with non-metastatic prostate cancer. (2018) (2)
[A multi-institutional questionnaire survey on surgical treatment for a small renal mass: factors related with decision-making in indications for partial nephrectomy]. (2012) (2)
Arteriovenous fistula after robot‐assisted laparoscopic prostatectomy: A rare case report (2019) (2)
[Primary transitional carcinoma of the remaining ureter after nephrectomy for pyonephrosis: a case report]. (2005) (2)
A narrative review of urinary phospholipids: from biochemical aspect towards clinical application (2021) (2)
Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinoma. (2021) (2)
Transition Behavior in the Use of Complementary and Alternative Medicine during Follow-up after Radical Prostatectomy: A Multicenter Survey in Japan (2010) (2)
[A case of elderly donor in living kidney transplant after radical radiotherapy for prostate cancer]. (2009) (2)
Large Retroperitoneal Mass Diagnosed as Adrenal Chronic Expanding Hematoma. (2015) (2)
[Development of molecular targeting drugs for the treatment of cancer-therapeutic potential and issues to be addressed in global development]. (2000) (2)
Solitary recurrence of prostate cancer surrounded by seminal vesicle/vas deferens‐like epithelium (2020) (2)
Association of ABCG2 polymorphisms with exposure and toxicity of sunitinib in a patient with renal cell carcinoma. (2010) (2)
[Progression from adenocarcinoma to small cell carcinoma of the prostate during endocrinotherapy: a case report]. (2001) (2)
Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening (2007) (2)
Average shapes of uroflow curves of adult men (2009) (2)
Assessment of lower urinary tract symptoms after Bacille Calmette-Guérin instillation therapy for non muscle-invasive bladder cancer (2012) (2)
[A case of adenocarcinoma arising in female urethral diverticulum]. (2002) (2)
[IgG4-related tubulointerstitial nephritis presented with multiple renal nodular lesions]. (2011) (2)
[Right ectopic ureter with ipsilateral renal agenesis presenting with infertility: a case report]. (2004) (2)
[A case of schwannoma in the renal hilum]. (2004) (2)
Evaluation of prognostic factors after radical prostatectomy in pT3b prostate cancer patients in Japanese population. (2015) (2)
[Molecular epidemiology and cancer prevention]. (2001) (2)
[A case of urolithiasis due to vitamin D intoxication in a patient with idiopathic hypoparathyroidism]. (2002) (2)
Novel constant‐pressure irrigation technique for the treatment of renal pelvic tumors after ipsilateral ureterectomy (2014) (1)
[Development of a preoperative criterion to select candidates for nerve-sparing radical prostatectomy at Kyoto University Hospital]. (2014) (1)
486 RALGAP α2, THE INACTIVATOR OF RAL SMALL GTPASE, IS A METASTASIS SUPPRESSOR OF BLADDER CANCER (2011) (1)
[Long-term clinical results of 5 cases of urachal carcinoma]. (2000) (1)
Exploring optimal sequence of abiraterone and enzalutamide in patients with castration-resistant prostate cancer: The Kyoto-Baltimore collaboration. (2017) (1)
Role of IL 13 RA 2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (2018) (1)
[Epididymal sperm aspiration for obstructive azoospermia]. (2000) (1)
Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: results from Japanese observational cohort (2014) (1)
Hormone Therapy and Castration Resistance of Prostate Cancer (2018) (1)
Clinical characteristics of renal transplant recipients who developed de novo donor-specific antigen in Kyoto University Hospital: a case series (2022) (1)
[Prognostic factors of prostatic cancer]. (1995) (1)
[Nocturia and the circadian rhythm]. (2013) (1)
801 The impact of ureteral ligation on clinical outcome during radical nephroureterectomy for upper urinary tract urothelial carcinoma: Multi-institutional case series study JCOG1110A (2016) (1)
Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of Hi 9 in (2016) (1)
[Two Cases of Metastatic and Recurrent Non-Clear Cell Renal Cell Carcinoma Re-Diagnosed as Renal Mucinous Tubular and Spindle Cell Carcinoma during Long-Term Follow-Up]. (2018) (1)
Long‐term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate‐targeted treatment and metastasis‐directed therapy (2021) (1)
Renal Cell Carcinoma Common Regions of Deletion on Chromosomes 5 q , 6 q , and 10 q Updated (2006) (1)
Carcinoma Cells by Adriamycin Enhancement of Fas-mediated Apoptosis in Renal Cell (2000) (1)
Obstructive azoospermia as an unusual complication associated with herniorrhaphy of an omphalocele: a case report (2011) (1)
Laparoscopic excision of an acquired ureteral diverticulum: A case report (2018) (1)
Abstract 2813: EP4 antagonist suppresses bone metastasis in prostate cancer. (2013) (1)
High Dose Local Irradiation to T3-4N0M0 Prostate Cancer with Intensity-modulated Radiotherapy Combined with Neoadjuvant Hormonal Therapy (2009) (1)
Insulin-like Growth Factor-binding Protein-3 Gene-202 A / C Polymorphism Is Correlated with Advanced Disease Status in Prostate Cancer 1 (2003) (1)
Retroperitoneal chylocoele following laparoscopic adrenalectomy: A case report (1996) (1)
[Subclassification of the D'Amico's high risk group to predict biochemical recurrence after radical prostatectomy]. (2012) (1)
[A case report of a young patient with invasive bladder cancer]. (2003) (1)
The Current Status and Challenges in Augmented-Reality Navigation System for Robot-Assisted Laparoscopic Partial Nephrectomy (2020) (1)
66: Subtyping of Uropathogenic Escherichia Coli According to Genetic Mosaicism in the Pathogenicity Island Encoding USP Protein (2005) (1)
[The influence over the long-term prognosis of BCG therapy and the surgical treatment in superficial bladder cancer treatment]. (2005) (1)
Systematic chemical screening identifies disulfiram as a repositionable drug that enhances sensitivity to cisplatin in bladder cancer: A summary of preclinical studies (2019) (1)
Prospective evaluation of a "Watchful Waiting" program using initial pathology criteria and PSA-doubling time monitoring for patients with stage T1c prostate cancer. (2006) (1)
Comparative analysis of perioperative outcomes between robot-assisted partial nephrectomy and open partial nephrectomy: a propensity-matched study (2021) (1)
Hormonal therapy for localized prostate cancer in Japan: The outcome of J-CaP database. (2012) (1)
[Initial Clinical Experience of Nivolumab for Metastatic Renal Cell Carcinoma]. (2018) (1)
Population-Based Survey of Overactive Bladder in Japan: A Cross-Sectional Analysis of the Nagahama study (2016) (1)
[BK virus nephropathy in a kidney transplant recipient: a case report and literature review]. (2006) (1)
Oxygen Species Cisplatin through the Accumulation of Intracellular Reactive Sensitizing Effect of Galectin-7 in Urothelial Cancer to Updated (2007) (1)
Protocol for development and validation of a prediction model for 5-year risk of incident overactive bladder in the general population: the Nagahama study (2021) (1)
Bladder urothelial carcinoma producing insulin‐like growth factor II: A case report (2018) (1)
Extrapolation of physiologically based pharmacokinetic model for tacrolimus from renal to liver transplant patients (2021) (1)
Multicenter randomized controlled trial of life style measures alone versus life style measures plus ramelteon for nocturia: an interim analysis (2014) (1)
ESTABLISHMENT OF NOVEL MOUSE BLADDER CANCER CELL LINES MIMICKING INTRINSIC SUBTYPE OF HUMAN INVASIVE BLADDER CANCER: MP88‐20 (2017) (1)
[A study on parameters to predict tumor volume for stage T1c prostate cancers of Gleason score 6 or less]. (2000) (1)
Phase II open-label study of S-588410 as maintenance monotherapy after first-line platinum-containing chemotherapy in patients with advanced or metastatic urothelial carcinoma. (2021) (1)
144 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES MULTIPLE NEW SUSCEPTIBILITY LOCI FOR PROSTATE CANCER IN JAPANESE POPULATION (2011) (1)
Prostate‐specific antigen density during dutasteride treatment for 1 year predicts the presence of prostate cancer in benign prostatic hyperplasia after the first negative biopsy (PREDICT study) (2021) (1)
[A case of prostate carcinosarcoma successfully treated with combined modality therapy]. (2013) (1)
Long-term safety of high-dose whole pelvic IMRT for high-risk localized prostate cancer through 10-year follow-up (2021) (1)
1149 FLUORESCENT IMAGING OF HIGH GRADE BLADDER CANCER USING A SPECIFIC ANTAGONIST FOR CHEMOKINE RECEPTOR CXCR4 (2010) (1)
A 45,X/46,XY Male with Orchidopexy Diagnosed with Mixed Germ Cell Tumor After 21-year Follow-up (2017) (1)
Thymic cancer mimicking a metastasis of testicular seminoma (2015) (1)
Re: Office based flexible cystoscopy may be less painful for men allowed to view the procedure. A. R. Patel, J. S. Jones, S. Angie and D. Babineau J Urol 2007; 177: 1843-1845. (2007) (1)
Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab (2022) (1)
Over expression of thioredoxin-1 in transgenic mice attenuates germ cell apoptosis induced by experimental cryptorchidism. (2004) (1)
775: Cell Culture Proteome Identifies CXCL 1 as a Secreted Marker and Mediator for the Tumor Invasion of Bladder Cancer (2007) (1)
Clinical significance of IDC‐P as predictive factor after intensity‐modulated radiation therapy (2022) (1)
Interim Outcomes of a High-dose Whole Pelvic IMRT for Very High-risk Group of Patients With Locally Advanced Prostate Cancer (2012) (1)
Living related renal transplantation for end‐stage renal disease after liver transplantation from a brain‐dead donor (2003) (1)
Non-drug lifestyle measures for the management of nocturia (2007) (1)
[Genetic analysis in prostate cancer]. (2014) (1)
[A Case of Rapidly Progressive Metastatic Castration-Resistant Prostate Cancer : Durable Control by Early Induction of Carboplatin and Paclitaxel]. (2015) (1)
[Perioperative agranulocytosis induced by immunosuppressants in a renal graft recipient : a case report]. (2014) (1)
Solid testicular mass in a 44-year-old man. (2013) (1)
[Post-Operative Urethral Stricture after Holmium Laser Enucleation of the Prostate]. (2019) (1)
Abstract 300: Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation (2010) (1)
[A case of retroperitoneal dedifferentiated liposarcoma initially diagnosed as malignant fibrous histiocytoma: a case report]. (2006) (1)
[Questionnaire survey on the theory of antimicrobial prophylaxis in urologic surgery]. (2004) (1)
[A case of amyloidosis of the ureter caused by primary macroglobulinemia]. (2011) (1)
255: Prognostic Prediction of Metastatic Prostate Cancer Using Genetic Polymorphisms (2005) (1)
[A case of malignant lymphoma with bilateral adrenal involvement]. (2003) (1)
Comparison of the Effects by Obybutynin and Tolterodine on Spina Bifida Patients: A Pilot Crossover Study (2011) (1)
Asia-1 Perspective role of the Urological Association of Asia (UAA) in the next decade(Future of Urology in Asia) (2011) (0)
Abstract 5046: High-throughput chemical screening for sensitization of bladder cancer to gemcitabine and cisplatin chemotherapy (2016) (0)
Evaluation of the Degree of Heat Conduction with the da Vinci Surgical System (2019) (0)
Survival outcomes of neoadjuvant hormone therapy plus external-beam radiotherapy with relatively early initiation of salvage hormone therapy to patients with T3-4N0M0 prostate cancer. (2011) (0)
MP24-15 CLINICAL UTILITY OF DETECTING LOW-FREQUENCY CELL-FREE DNA VARIANTS IN CASTRATION-RESISTANT PROSTATE CANCER (2021) (0)
375 Clock gene Rev-erbβ competes with Rev-erbα for transactivation of the connexin43 gene expression, coding a gap-junction protein in urinary bladder (2014) (0)
[A case of membranous glomerulonephritis in renal allograft]. (2002) (0)
Expression of PTHrP and PTH/PTHrP receptor 1 (PTH1R) in normal and diseased bladder detrusor muscle. (2013) (0)
[Xanthogranulomatous pyelonephritis presenting a subcutaneous mass in the lower abdomen: a case report]. (2006) (0)
434 Four loci at 11q12, 10q26, 3p11.2, and 2p11 are associated with prostate cancer susceptibility in the Japanese population (2012) (0)
Involvement of SDF-1 in recruitment of alpha smooth muscle actin-positive cells to the urinary bladder. (2011) (0)
Laparoscopic Forceps with Force Feedback (2018) (0)
155: Clinical Implication of Vascular Endothelial Growth Factor (VEGF) T-460c Polymorphism in the Risk and Progression of Prostate Cancer (2007) (0)
Sequential Therapy with Docetaxel and Cabazitaxel Starting at Low PSA Levels was Associated with Longer Survival in Patients with Castration-Resistant Prostate Cancer (2021) (0)
MP60-02 SINGLE NUCLEOTIDE POLYMORPHISMS IN SLC45A3 AND KLK3 ARE CORRELATED WITH SERUM PSA LEVELS AND ARE POTENTIAL BIOMARKERS FOR DETECTING PROSTATE CANCER (2015) (0)
424: Androgen Dependent Activation of Protein Kinase Cζ and its Roles of Androgen-Independent Cell Proliferation in Prostate Cancer Cells (2006) (0)
[Clinical results of immunosuppressive triple therapies in living-related renal transplantation--a single center experience]. (2004) (0)
Gap junction regulates detrusor activity in bladder inflammation. (2016) (0)
QUANTITATIVE ANALYSIS OF VEGF, VEGF-C AND VEGFR-2 GENE EXPRESSION IN RENAL CELL CARCINOMA (1999) (0)
Enzalutamide plus androgen deprivation therapy (ADT) versus flutamide plus ADT in men with castration-resistant prostate cancer (CRPC): AFTERCAB. (2021) (0)
A comparison of laparoendoscopic single-site surgery versus conventional procedures for laparoscopic donor nephrectomy: a Japanese multi-institutional retrospective study (2019) (0)
MP57-08 PROSTATE-SPECIFIC ANTIGEN DENSITY IS THE MOST APPROPRIATE FACTOR FOR DETECTING UNFAVORABLE PATHOLOGY AFTER RADICAL PROSTATECTOMY IN MEN ELIGIBLE FOR ACTIVE SURVEILLANCE FROM MUTLI-INSTITUTIONAL STUDY (2016) (0)
The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients (2019) (0)
Molecular genetic analysis of human renal tumors by using restriction fragment length polymorphisms (1994) (0)
MP2-19 SUBSTRATIFICATION OF D'AMICO HIGH RISK PROSTATE CANCER REVEALS CLINICALLY DISTINCT POPULATIONS: AN AMERICAN VALIDATION OF THE JAPANESE MODEL (2014) (0)
COMPARATIVE ANALYSIS OF POST-TREATMENT BIOCHEMICAL OUTCOMES OF LOCALISED PROSTATE CANCER IN A JAPANESE POPULATION: WHAT IS THE BEST APPROACH FOR HIGH-RISK PATIENTS? (2006) (0)
Erratum to: Urinary Protein Markers for the Detection and Prognostication of Urothelial Carcinoma. (2018) (0)
Dose-intensive chemotherapy with syngeneic peripheral blood stem cell support for poor risk germ cell tumor of extragonadal origin: a case report. (2002) (0)
MP41-01 IMPACT OF HISTOLOGICAL VARIANTS ON CLINICAL OUTCOMES IN PATIENTS WITH CHEMORESISTANT UROTHELIAL CANCER TREATED WITH PEMBROLIZUMAB: A PROPENSITY SCORE MATCHING ANALYSIS (2021) (0)
Is Adjuvant Hormonal Therapy Necessary to Japanese Patients with Locally Advanced Prostate Cancer Treated by 3D-CRT? (2008) (0)
Title Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy (2019) (0)
Oncogenes in Renal Cell Carcinoma (1995) (0)
[A case of accelerated acute rejection in kidney transplantation rescued by plasma exchange]. (2005) (0)
PURINE-RICH ELEMENT BINDING PROTEIN ALPHA INDUCES CELL STRESS AND DIFFERENTIATION PATHWAYS IN PROSTATE CANCER CELLS (2009) (0)
511 INCIDENCE OF BLADDER CANCER AFTER CURATIVE RADIATION THERAPY VERSUS RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER (2012) (0)
3D-CRT and IMRT for prostate cancer (2005) (0)
[A Case of Primary Ewing Sarcoma of the Kidney Treated with Multidisciplinary Approach]. (2020) (0)
204 NARDILYSIN IS ASSOCIATED WITH PROSTATE CANCER AGGRESSIVENESS AND IS A POTENTIAL TISSUE AND SERUM MARKER (2013) (0)
[Cross-sectional survey of voiding habits in male patients undergoing ileal neobladder reconstruction]. (2009) (0)
110 The expression profile of phosphatidylinositol in high resolution imaging mass spectrometry is a potential biomarker for prostate cancer (2014) (0)
395: Expression Analysis of NDRG1, An Androgen-Induced, Stress Responsive Gene, in Prostate Cancer (2005) (0)
66 Parathyroid hormone related peptide is endogenous relaxant of spontaneous detrusor smooth muscle contraction (2013) (0)
468: Polymorphic CA Repeats in IGF-I Gene is a Common Genetic Modifier in the Etiology of Prostate Cancer and Benign Prostatic Hyperplasia (2004) (0)
EP-1309: Long-term outcome of IMRT with neoadjuvant hormonal therapy under early salvage policy for T3-4N0M0 prostate cancer (2014) (0)
MP09-16 IDENTIFICATION OF IL13RA2 AS A BIOMARKER FOR PREDICTING CASTRATION-RESISTANCE OF PROSTATE CANCER USING PATIENT DERIVED XENOGRAFT MODELS (2020) (0)
[Experience of transobturator sling for iatrogenic male stress urinary incontinence]. (2013) (0)
[Multi-institute survey on actual conditions of urologic management for severe bladder dysfunction after hysterectomy]. (2008) (0)
PD44-01 NOT A STRAIGHTFORWARD RELATION BETWEEN ESTIMATED DAILY SODIUM INTAKE AND NOCTURIA: THE NAGAHAMA STUDY (2020) (0)
Basic fibroblast growth factor (bFGF) could be a key regulator for myogenic bladder overactivity through gap junction generation in the smooth muscle. (2010) (0)
smooth muscle overactivity through gap junction generation in the Basic fibroblast growth factor causes urinary bladder (2016) (0)
MP-16.14 Improved Grouping System Combining Gleason Score for Group IV of TNM Prognostic Grouping for Prostate Cancer: Results from J-CAP Database (2011) (0)
Outcomes of high-dose whole pelvic simultaneous integrated boost IMRT in patients with pelvic lymph node-positive prostate cancer. (2019) (0)
Prediction of survival in patients with metastatic prostate cancer by single nucleotide polymorphisms of cancer-associated genes. (2012) (0)
1A1-F07 Development of Low-Cost Soft Organ Model with Virtual Tumors (2015) (0)
External-beam radiotherapy combined with neoadjuvant hormonal therapy (2007) (0)
p2PSA-associated parameters are significant predictors of reclassification of first-year protocol biopsy on active surveillance for early-stage prostate cancer patients: From the PRIAS-JAPAN study. (2021) (0)
Abstract 4677: Non-prostate cancer death within 5 years after radical therapy in men with localized prostate cancer. (2013) (0)
Successful surgical management of recurrent urachal adenocarcinoma: A case report (2020) (0)
STAT3 Polymorphism Associates With mTOR Inhibitor-Induced Interstitial Lung Disease in Patients With Renal Cell Carcinoma (2022) (0)
Absence of Association between E-Cadherin Gene Polymorphism at Position-160 in Promoter Region and Risk of Urothelial Cancer (2003) (0)
Reply by Authors. (2019) (0)
Subjective and objective assessment of efficacy and tolerability of mirabegron, a ß(3)-adrenoceptor agonist, in clinical use (2013) (0)
BALB/C-FCGR2B-/-PDCD-/- MOUSE EXPRESSING ANTI-UROTHELIAL ANTIBODY IS A MODEL OF AUTOIMMUNE CYSTITIS (2009) (0)
1583: PSA-Doubling Time Assessment Based Upon 4 Consecutive Measurements for 6 Months: Is it a Realistic Strategy to Spare Over-Treatment for Patients with Stage T1C Prostate Cancer Presenting Favorable Biopsy Features? (2006) (0)
644: Impact of Galectin 7 Expression on the Chemosensitivity of Urothelial Cancer (2006) (0)
PD23-04 THE POTENTIAL UTILITY OF CHEMOKINE CXCL1 (GROα) AS A NOVEL DIAGNOSTIC AND PROGNOSTIC MARKER FOR BLADDER CANCER (2015) (0)
POS-02.09: Triptolide (PG490)-mediated sensitization of urothelial cancer cells to cisplatin via the interaction between glycogen synthase kinase-3β and p53 (2007) (0)
202 Discovery of urinary biomarker candidates for prostate cancer based on proteomic analyses (2014) (0)
535 The obesity paradox in nocturia? Lower body mass index is a risk factor of mortality in outpatients with nocturia in Japan (2016) (0)
A modified bioinformatics approach of detecting low-frequency mutations in cell-free DNA to achieve precision medicine for advanced prostate cancer (2019) (0)
[Laminectomy for spinal cord compression occurring in hormone refractory prostate cancer]. (2002) (0)
Allelic Imbalances on Chromosome 20 in Human Transitional Cell Carcinoma (2000) (0)
CIRCADIAN RHYTHM COORDINATES ATP RELEASE IN THE UROTHELIUM VIA CONNEXIN43 HEMICHANNELS.: PD70‐11 (2017) (0)
322 RISK ESTIMATION MODEL WITH MULTIPLE COMMON GENETIC VARIANTS FOR JAPANESE PROSTATE CANCER (2012) (0)
The effects of Gosha-Jinki-Gan, a blended herbal medicine, and furosemide for nocturnal polyuria with elevated B-type natriuretic peptide: a crossover trial. (2010) (0)
ENDOTHELIAL FENESTRATION OF TUMOUR MICROVASCULATURE AS A PREDICTIVE FACTOR OF ANTI-VEGF THERAPY IN CLEAR CELL RENAL CELL CARCINOMA (2008) (0)
Japanese Population Prostate Cancer and Benign Prostatic Hyperplasia in a Gene Polymorphism with Vitamin D Receptor Association of Updated Version (2000) (0)
RHEB, A NOVEL SMALL G-PROTEIN OF RAS SUPERFAMILY, IS ASSOCIATED WITH PROLIFERATION IN HUMAN PROSTATE CANCER CELL LINES (2006) (0)
Relaxation of IGF2/H19 imprinting in Wilms tumour is associated with a switch in DNA methylation (1994) (0)
Correlates of nocturnal voiding in women: cardiovascular and metabolic factors (2011) (0)
Association of Vitamin D Receptor Gene Polymorphism with Prostate Cancer and Benign Prostatic Hyperplasia in a Japanese Population 1 (2000) (0)
Patient-Derived Urothelial Cancer Xenograft Models: A Systematic Review and Future Perspectives (2020) (0)
1085 Adverse event profiles of alpha-1 blocker agents for male patients: Data mining of the public version of the FDA adverse event reporting system (2013) (0)
170 Identification of novel microRNAs associated with epithelial-mesenchymal transition in human bladder cancer by miRNA chip array profiling (2012) (0)
[A case of small cell carcinoma of the ureter]. (2008) (0)
The development of a 3D navigation system for robot-assisted partial nephrectomy using augmented reality technology (2019) (0)
Influence of Cigarette Smoking and Schistosomiasis on p53 Gene Mutation in Urothelial Cancer1 (2006) (0)
MP09-18 MISSENSE POLYMORPHISM IN SRD5A2 IN COMBINATION WITH HSD3B1 VARIATION IS ASSOCIATED WITH OUTCOME OF CASTRATION-RESISTANT PROSTATE CANCER PATIENTS TREATED WITH ABIRATERONE (2020) (0)
MP-16.15: Endothelial fenestration of tumor microvasculature as a predictive factor of anti-VEGF therapy in clear cell renal cell carcinoma (2007) (0)
A Pilot Study of Hypofractionated Intensity Modulated Radiation Therapy Over 3 Weeks for Localized Prostate Cancer (2016) (0)
Abstract 1575: ARF regulates the stability of p16 protein via REGγ-dependent proteasome degradation (2014) (0)
1102 Guideline adherence of immediate post-TUR intravesical chemotherapy for patients with non-muscle invasive bladder cancer (2014) (0)
[Deceased Donor Kidney Transplantation from a Liver Transplantation Recipient]. (2016) (0)
Development and validation of prediction model for incident overactive bladder: The Nagahama study (2022) (0)
MP5-03 ADHERENCE AND ADEQUACY OF THE BLADDER CANCER GUIDELINES FOR POST-TUR FOLLOW-UP INTERVAL (2015) (0)
ANDROGEN-DEPENDENT REGULATION OF PROTEIN KINASE Cζ AND ITS ROLES FOR PROGRESSION TO ANDROGEN INDEPENDENCY IN PROSTATE CANCER CELLS (2008) (0)
Title A 45,X/46,XY Male with Orchidopexy Diagnosed with Mixed Germ Cell Tumor After 21-year Follow-up (2018) (0)
Title Up-regulation of miR-582-5 p regulates cellular proliferation ofprostate cancer cells under androgen-deprived conditions (2019) (0)
7030 POSTER Outcomes of Intensity-Modulated Radiation Therapy Combined With Neoadjuvant Hormonal Therapy for High-risk Prostate Cancer (2011) (0)
MP03-07 IMPACT OF PRIOR INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER ON THE EFFICACY OF PEMBROLIZUMAB IN PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA (2022) (0)
HIGH‐THROUGHPUT CHEMICAL SCREENING FOR SENSITIZATION OF BLADDER CANCER TO GEMCITABINE AND CISPLATIN CHEMOTHERAPY: MP44‐19 (2017) (0)
MP03-15 LAPAROSCOPIC ADRENALECTOMY FOR METASTATIC TUMORS IS FEASIBLE FOR SELECTED PATIENTS: RETROSPECTIVE MULTICENTER STUDY IN JAPANESE POPULATIONS (2018) (0)
[Significance of chromosome 9 alterations as an initial step in urothelial carcinogenesis]. (2000) (0)
[A Case of Pelvic Unicentric Castleman Disease Treated by Preoperative Transcatheter Arterial Embolization and Tumor Complete Resection with Combined Lower Abdominal and Posterior Approach]. (2021) (0)
MP16-17 GENOMIC LANDSCAPE OF METASTATIC HORMONE- NAÏVE PROSTATE CANCER (2020) (0)
2052 INSULIN-LIKE GROWTH FACTOR-I (IGF-I) POLYMORPHISMS PREDICT THE SURVIVAL OF PROSTATE CANCER PATIENTS WITH BONE METASTASIS AT INITIAL PRESENTATION (2010) (0)
Tumor targeting of gene expression through metal-coordinated conjugation with dextran [J. Control. Release (2003) 88 297-312]. (2016) (0)
[The prognostic value of adjuvant and neoadjuvant chemotherapy in total cystectomy for locally advanced bladder cancer]. (1999) (0)
INFLUENCE OF POLYMORPHISMS AND EXPRESSION OF CHROMOGRANIN A AND ENDOTHELIN-1 ON THE DEVELOPMENT AND PROGRESSION OF PROSTATE CANCER (2009) (0)
738: Low-Level Expression of EphA2 is Associated with P53 Mutations and Intravesical Recurrence in Bladder Cancer (2004) (0)
Association of sunitinib pharmacokinetics with toxicity and genetic polymorphism in efflux transporter ABCG2 in patients with renal cell carcinoma. (2011) (0)
MP35-13 IL13RA2 MEDIATES RESISTANCE TO SUNITINIB IN PRIMARY XENOGRAFT MODELS OF CLEAR CELL RENAL CELL CARCINOMA (2014) (0)
Prediction of survival in patients with metastatic prostate cancer by single nucleotide polymorphisms of cancer-associated genes. (2012) (0)
Retraction Note: In Vitro Transfection of Plasmid DNA by Amine Derivatives of Gelatin Accompanied with Ultrasound Irradiation (2020) (0)
Grand Rounds Solid Testicular Mass in a 44-Year-Old Man (2013) (0)
Symposium Organizers (2018) (0)
Regional distribution of lymph node metastasis in upper urinary tract urothelial cancer, sub-analysis of large multi-institutional study (JCOG1110A) (2018) (0)
99mTc-mercaptoacetyltriglycine Cortical Renography Predicts Outcomes in Adult Living Donor Renal Transplant Recipients. (2020) (0)
2234 A COMMON GENETIC VARIANTS BASED RISK PREDICTION MODEL FOR PROSTATE CANCER IS HIGHLY REPRODUCIBLE IN JAPANESE, AND COMPENSATES FOR PROSTATE SPECIFIC ANTIGEN AT GRAY-ZONE (2013) (0)
[A case of growing teratoma syndrome; long-term control accomplished by systemic interferon therapy with adequate local therapies]. (2015) (0)
UP-2.069: Upregulation of JunB by the Inactivation of Von Hippel-Lindau Tumor Suppressor Protein Induces Angiogenesis and Promotes Tumor Growth Via MMP-2 Upregulation (2009) (0)
[A case report: recurrence of urothelial cancer in an ileal conduit]. (2009) (0)
Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1 (2022) (0)
[Presurgical treatment of axitinib reduced operation risk by downsizing the vena cava tumor thrombus in advanced renal cell carcinomas: two case reports]. (2014) (0)
Predictors of the efficacy of non-drug lifestyle modifications for the management of nocturia (2009) (0)
[A case of late perirenal fat recurrence after partial nephrectomy for T1A renal cell carcinoma]. (2014) (0)
426: Basic Fibroblast Growth Factor (BFGF) Promotes Bladder Smooth Muscle Cell Proliferation and Matrix Remodeling through ERK1/2 Pathway (2007) (0)
446: Hypoxia Inducible Factor-Independent Function of PVHL and Its Roles on the Development of Familial Pheochromocytoma (2007) (0)
138 Exploring a novel therapeutic target for neuroendocrine prostate cancer using a xenograft model of trans-differentiation (2016) (0)
DISTRIBUTION OF LYMPH NODE METASTASIS IN UPPER URINARY TRACT UROTHELIAL CANCER, SUB‐ANALYSIS OF JCOG1110A STUDY: MP71‐18 (2017) (0)
[A case of renal cell carcinoma associated with paraganglioma]. (2011) (0)
Safe and effective administration of BCG for bladder carcinoma in situ after umbilical cord blood stem cell transplantation (2017) (0)
[The Safety of Laparoscopic Radical Cystectomy during Initial Phases in a Japanese Multicenter Cohort]. (2019) (0)
[Two-stage nephron-sparing surgery for bilateral T2 renal cell carcinoma and von Hippel-Lindau disease: a case report]. (2009) (0)
Phase I clinical study of cabazitaxel plus prednisolone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in a Japanese population. (2014) (0)
MP41-08 AMINO-TERMINAL ENHANCER OF SPLIT/AES IS A TUMOR AND METASTASIS SUPPRESSOR OF PROSTATE CANCER (2014) (0)
[Urologic laparoscopy]. (2000) (0)
MP35-15 DEVELOPMENT AND VALIDATION OF A NOVEL PROGNOSTIC MODEL FOR PREDICTING OVERALL SURVIVAL IN TREATMENT NAIVE CASTRATION-SENSITIVE METASTATIC PROSTATE CANCER. (2018) (0)
EP-1125 OUTCOMES OF HIGH DOSE DYNAMIC CONFORMAL ARC IRRADIATION FOR PATIENTS WITH T1C-T2N0M0 PROSTATE CANCER (2012) (0)
Dynamic Roles of GTP Metabolism in Cancers—Challenge for a New, Selective and Safe Approach to Eradicate Cancers (2016) (0)
Barriers for sperm cryopreservation in advanced germ cell tumor patients: a 20-year experience (2020) (0)
Masked acute rejection of the graft kidney under the recovery of native kidneys in a patient who underwent simultaneous liver and kidney transplantation (2020) (0)
75 STAT3 polymorphism can predict clinical benefits of interferon-α in patients with metastatic renal cell carcinoma (2012) (0)
The role of adjuvant chemotherapy for pT2-4 upper urinary tract urothelial cancer: Exploratory analysis of large multi-institutional study (JCOG1110A). (2019) (0)
[Transitional cell carcinoma in prostate after intravesical instillation of Bacillus Calmette-Guerin]. (2004) (0)
287 Amino-terminal enhancer of split/AES is a tumor and metastasis suppressor of prostate cancer (2015) (0)
MP-15.09: Functional Analysis of a Novel Soft Tissue Sarcoma Metastasis-Associated Molecule in Prostate Cancer (2009) (0)
Abstract 1920: Variation of ERG oncoprotein expression in prostate cancer patients with different ethnicities. (2013) (0)
VITAMIN D RECEPTOR GENE POLYMORPHISMS AS A GENETIC MARKER FOR PROSTATE CANCER PREDISPOSITION (1999) (0)
An analysis of STAT3 polymorphism on outcomes of interferon-alpha treatment in patients with metastatic renal cell carcinoma. (2011) (0)
MECHANISMS OF ACQUIRING ANDROGEN-INDEPENDENCE IN NOVEL PROSTATE CANCER XENOGRAFT MODEL (2008) (0)
Nocturia versus Insomnia or Sleep Apnea Syndrome: Comparisons of Patient Characteristics in Outpatient Clinics (2010) (0)
Mortality of outpatients with nocturia is not higher than that of the Japanese population (2013) (0)
2287 PREDICTION OF SURVIVAL IN METASTATIC PROSTATE CANCER PATIENTS BY SNP ARRAY ANALYSIS OF CANCER-ASSOCIATED GENES (2011) (0)
[Socioeconomic advantages of longer screening intervals for men with low prostate-specific antigen levels in prostate cancer mass screening]. (2013) (0)
MP-17.12: Bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient (2006) (0)
Use of STAT3 polymorphisms to predict overall survival in patients treated with interferon-alpha for metastatic renal cell carcinoma. (2012) (0)
839 RalGAP, the inactivator of Ral small GTPase, suppresses the progression of prostate cancer (2012) (0)
ENDOTHELIAL FENESTRATIONS IN TUMOR MICROVASCULATURE AS A POTENT PREDICTIVE MARKER OF ANTI-VEGF THERAPY IN CLEAR CELL RENAL CELL CARCINOMA (2009) (0)
[Diagnosis and treatment of prostate cancer--it's diversity and future prospects]. (2001) (0)
607 A FUNCTIONAL VARIANT IN NKX3.1 ASSOCIATED WITH PROSTATE CANCER SUSCEPTIBILITY DOWN-REGULATES NKX3.1 EXPRESSION (2011) (0)
in Prostate Cancer Polymorphism Is Correlated with Advanced Disease Status C / A Insulin-like Growth Factor-binding Protein-3 Gene-202 Updated (2003) (0)
INTRAVESICAL PROSTATIC PROTRUSION IS NOT THE SAME IN ITS SHAPE: EVALUATION BY PREOPERATIVE CYSTOSCOPY AND OUTCOME IN HOLEP: MP02‐12 (2017) (0)
Title Late recurrence of nonseminomatous germ cell tumor successfully treated with intensity-modulated radiation therapy (2018) (0)
Hormonal therapy for localized prostate cancer in Japan: The outcome of J-CaP database. (2012) (0)
MP49-14 PREDICTIVE VALUE OF RADIOLOGICAL RESPONSE RATE FOR PATHOLOGICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY AND POST-CYSTECTOMY SURVIVAL OF BLADDER UROTHELIAL CANCER (2016) (0)
Constitutional relaxation of insulin-like growth factor II gene implicated in Wilms' tomor (1993) (0)
549 Prediction of survival in metastatic prostate cancer patients by single nucleotide polymorphisms of cancer-associated genes (2012) (0)
Enhanced expression of plasmid dna - cationized gelatin complex by ultrasound in murine muscle [J. Control. Release 80 (2002) 345-356]. (2016) (0)
FP281POST-TRANSLATIONAL MODIFICATION OF MRP8 (S100A8) AND ITS ROLE IN CHRONIC KIDNEY DISEASE (2018) (0)
[Detection of prostate-specific antigen mRNA in preoperative peripheral blood of patients with prostate cancer: relationship to pathological parameters of the surgical specimens]. (1999) (0)
[A Case of Advanced Right Renal Pelvic Cancer with Left Supraclavicular Lymph Node Metastasis that Attained Long-Term Survival by Multidisciplinary Treatments]. (2019) (0)
[Complete Remission of Metastatic Renal Cell Carcinoma with Invasion of the Duodenum and Pancreas after Treatment with Nivolumab Plus Ipilimumab Followed by Axitinib and Surgery : A Case Report]. (2021) (0)
258 DEVELOPMENTAL ANALYSIS OF MICTURITION IN INFANT MOUSE IMMEDIATELY AFTER WEANING MEASURED BY A NEW RECORDING SYSTEM, AUTOMATED VOIDED STAIN ON PAPER (AVSOP) METHOD (2011) (0)
[Pseudohypoaldosteronism type 1 in an infant with bilateral primary obstructive megaureter : a case report]. (2011) (0)
[Kidney Auto-Transplantation for Intraoperative Right Renal Artery Injury in a Single Kidney Patient : A Case Report]. (2019) (0)
Dynamic role of GTP-energy metabolism in metastasis of renal cell carcinomas: Prognosis and therapeutic applications. (2016) (0)
MP-20.01: Fluorescent Imaging of Bladder Cancer Using T140 Analogue, A CXCR4 Antagonistic Peptide (2009) (0)
[Promotion of Diversity in the Academic Field of Urology : Analysis of 10,000 Articles Published in Acta Urologica Japonica during a 65-Year Period]. (2021) (0)
PD50-08 INSOMNIA INDUCES LOWER URINARY TRACT SYMPTOMS: THE NATURAL HISTORY AND RISK FACTORS FOR LUTS FROM THE NAGAHAMA LONGITUDINAL STUDY (2018) (0)
677 IDENTIFICATION OF EP4 AS A POTENTIAL TARGET FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER USING A NOVEL XENOGRAFT MODEL (2010) (0)
PD49-06 EXTRACELLULAR VESICLES SECRETED BY BONE TROPIC RENAL CELL CARCINOMA INDUCE ANGIOGENESIS IN BONE MARROW WITH POTENTIAL TO FACILITATE BONE METASTASIS (2021) (0)
PD49-10 EFFECT OF CYTOTOXIC T LYMPHOCYTE REGENERATED FROM IPS CELLS IN PRECLINICAL MODELS OF RENAL CELL CARCINOMA (2021) (0)
[Clinical Effect of Nivolumab on Advanced Renal Cell Carcinoma with Peritoneal Metastasis]. (2019) (0)
669 A phase III, multicenter, randomized, controlled study of maximum androgen blockade with vs without zoledronic acid in prostate cancer patients with metastatic bone disease: Results of main secondary endpoints in ZAPCA trial (2015) (0)
Title Expression of parathyroid hormone / parathyroid hormone-related peptide receptor 1 in normal and diseased bladder detrusor muscles : A clinico-pathological study (2018) (0)
[A case of bladder paraganglioma managed by transurethral approach, using holmium laser]. (2010) (0)
MP-15.03: EP4 Is a Novel Potential Target for the Treatment of Androgen-Independent Prostate Cancer (2009) (0)
Reply by Authors. (2020) (0)
Development of a Multiplex RNAUrine Test for the Detection and Stratification ofTransitional Cell Carcinoma of the Bladder (2008) (0)
[Significance of PSA nadir as a tool of predicting biochemical failure after radical prostatectomy for prostate cancer]. (2011) (0)
615 Pathological outcomes after radical prostatectomy in men eligible for active surveillance, multi-institutional study (2016) (0)
Gene expression Genomic characterization of multiple clinical phenotypes of cancer using multivariate linear regression models (2007) (0)
PTHrP signalling system is activated by acute bladder distension (2012) (0)
Asian School of Urology, Young Leaders' Workshop, Kyoto 2010 (2011) (0)
[Molecular and endocrinological mechanism of benign prostatic hyperplasia and prostate cancer]. (2002) (0)
[Pelvic lymph node dissection in robot-assisted laparoscopic radical prostatectomy: safety and adequacy in introductory series]. (2015) (0)
247: The Role of F70 S6K Pathways in the Progression to Androgen Independent Cell Proliferation in Prostate Cancer Cells (2005) (0)
[Therapeutic strategy for prostate specific antigen (PSA) failure after radical prostatectomy]. (2003) (0)
MP28-08 INTRAVITAL TWO-PHOTON IMAGING OF BLADDER REVEALED THE ACTIVATION OF UROTHELIAL ERK BY STRETCH-INDUCED INTRAVESICAL RELEASE OF ADENOSINE TRIPHOSPHATE (2020) (0)
Title Amino-terminal enhancer of split gene AES encodes a tumorand metastasis suppressor of prostate cancer (2019) (0)
Current status of systemic chemotherapy for octogenarians with advanced urothelial cancer in Japan: a Japanese multi-institutional study (CURE study) (2016) (0)
[Hemorrhagic adrenocortical adenoma with myelolipoma: a case report]. (2006) (0)
787 ASSOCIATION OF GENETIC POLYMORPHISMS AT 8Q24 WITH THE RISK OF PROSTATE CANCER IN A JAPANESE POPULATION (2009) (0)
PD13-11 LONGER INTERVAL BETWEEN DISEASE ONSET AND TREATMENT INITIATION IS ASSOCIATED WITH UNFAVORABLE PATHOLOGICAL AND ONCOLOGICAL OUTCOMES OF NEPHROURETERECTOMY FOR UPPER URINARY TRACT UROTHELIAL CANCER (2016) (0)
1390: GSTT1 Polymorphism is Associated with Improvement of Seminal Findings after Varicocelectomy (2004) (0)
1324: Gemcitabine and Paclitaxel Regimen for Patients with Advanced Transitional Cell Carcinoma (2005) (0)
Differences and Associations between Night-time Frequency/Nocturia and Sleep Disorders (2009) (0)
Circadian rhythms of micturition during jet lag. (2018) (0)
604: Immunohistochemical Analysis of Dihydropyrimidine Dehydrogenase and Thymidylate Synthase Expression in Prostate Cancer (2004) (0)
Triptolide (PG490)-mediated sensitization of urothelial cancer cells To Cisplatin-induced apoptosis (2006) (0)
684 IN VITRO CULTURE OF SPERMATOGONIAL STEM CELLS FROM AZOOSPERMA PATIENTS (2011) (0)
[Activation of imprinted genes in human carcinogenesis]. (1995) (0)
[Salvage hormonal therapy against recurrence after curative external beam radiotherapy for locally advanced prostate cancer at Kyoto University Hospital]. (2012) (0)
Add-on effects of tadalafil for tamsulosin-treated patients with benign prostatic hyperplasia suffering from residual lower urinary tract symptoms: a randomized, placebo-controlled, double-blind, crossover study (2019) (0)
S14-5 Management of high risk superficial bladder cancer : the timing of radical cystectomy(Symposium 14「Management of Superficial Bladder Cancer」) (2006) (0)
[Renal artery pseudoaneurysm following retroperitoneal laparoscopic partial nephrectomy]. (2009) (0)
[Simultaneous Hepatorenal Transplantation from a Brain-Dead Donor for Graft Dysfunction and Renal Insufficiency in a Liver Transplant Recipient : A Case Report]. (2017) (0)
Kit and method for detecting urothelial carcinoma (2006) (0)
109: Higher Biofilm Productivity in Escherichia Coli Strains Isolated from Prostatitis Patients, Compared those from Cystitis and Pyelonephritis (2004) (0)
Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese patients. (2012) (0)
PROSTATE CANCER LOCI WITH NEGATIVE MULTIPARAMETRIC MRI FOR PROSTATE CANCER: CORRELATION WITH PROSTATECTOMY SPECIMENS: MP20‐08 (2017) (0)
Dietary counseling focused on sodium restriction reduces nocturnal urine volume and nocturnal polyuria index in renal allograft recipients with nocturnal polyuria (2016) (0)
509 UPSTREAM REGULATORS FOR ANDROGEN-DEPENDENT ACTIVATION OF ATYPICAL PROTEIN KINASE C IN PROSTATE CANCER CELLS AND THEIR ROLES FOR ANDROGEN-INDEPENDENT PROGRESSION (2009) (0)
[Urinary diversion in patients treated with pelvic irradiation: transverse colon conduit revisited]. (2014) (0)
Retroperitoneoscopic nephrectomy for polycystic kidney disease (2007) (0)
OF SERUM p 53 ANTIBODIES IN PATIENTS WITH UPPER URINARY TRACT TUMORS (2005) (0)
Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN (2021) (0)
1761 CLINICAL CHARACTERISTICS OF XP11.2 TRANSLOCATION RENAL CELL CARCINOMA IN ADULT JAPANESE PATIENTS (2011) (0)
Left renal mass presenting uncommon pattern of extension in a patient with intestinal malrotation (2017) (0)
Importance of performance status, corrected calcium, and microvascular invasion in predicting overall survival in patients with metastatic renal cell carcinoma at the era of molecular targeted therapy. (2013) (0)
[Clinical Utility of Upper Urinary Tract Reconstruction by Ileal-Ureter Substitution]. (2018) (0)
Pilot study of moderately-hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer. (2018) (0)
MP26-16 PERFORMANCE OF PROMPT-PROSTATE GENETIC SCORE IN A JAPANESE COHORT (2021) (0)
IDENTIFICATION OF NINE NEW SUSCEPTIBILITY LOCI FOR PROSTATE CANCER IN THE JAPANESE POPULATION: MP70‐09 (2018) (0)
Preoperative nomogram for predicting locally advanced disease in patients with upper urinary tract urothelial carcinoma (2018) (0)
[Recent advancements in prostate cancer basic research]. (2016) (0)
Re: Impact of Nocturia on Mortality: The Nagahama Study. (2020) (0)
[A case of successful living related renal transplantation in a patient with end-stage renal disease resulting from sarcoidosis]. (2014) (0)
The Prostate 68 : 1689 ^ 1695 ( 2008 ) AssociationofGeneticPolymorphismsat 8 q 24 Withthe Riskof ProstateCancer in a Japanese Population (2008) (0)
MP12-19 SPONTANEOUS MICTURITION BEHAVIOR AND CYSTOMETRIC EVALUATION OF BLADDER FUNCTION IN P2X7 RECEPTOR DEFICIENT MICE (2015) (0)
Pannexin 1 channels participate in urothelial ATP release and signaling. (2014) (0)
[A case of giant perirenal malignant lymphoma: a case report]. (2002) (0)
Abstract 2041: High-throughput chemical screening for sensitization of bladder cancer to gemcitabine and cisplatin chemotherapy (2017) (0)
54: Escherichia Coli from Uncomplicated and Complicated Cystitis and from Asymptomatic Bacteriuria Possess Similar Phylogeny, Virulence Genes and O Serogroup Profiles (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Osamu Ogawa?

Osamu Ogawa is affiliated with the following schools:

Osamu Ogawa's Academic­Influence.com Rankings

Osamu Ogawa's Degrees

Why Is Osamu Ogawa Influential?

Osamu Ogawa's Published Works

Published Works

What Schools Are Affiliated With Osamu Ogawa?

Osamu Ogawa's AcademicInfluence.com Rankings